Data / Research funding / Kidney Disease
Kidney Disease: 2,622 NIH awards ($3B) to 336 organizations
2,622 NIH awards ($3B) in the NIH spending category Kidney Disease, to 336 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 2,622 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Center for Quantitative Biology: A focus on "omics", from organisms to single cells | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $17,122,562 | August 1, 2019 | June 30, 2029 | WHITFIELD, MICHAEL L | reporter.nih.gov |
| Assessment of Biomarker Guided CNI Substitution in Kidney Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $16,391,930 | July 1, 2025 | June 30, 2029 | HEEGER, PETER SCOTT | reporter.nih.gov |
| Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,843,451 | August 20, 2021 | May 31, 2028 | NAJI, ALI | reporter.nih.gov |
| Extracellular Vesicles for Gaining Insights into Tissue Senescent Signatures: A SenNET Pilot and Exploratory Project | NIH | National Institute on Aging | 2021 to 2025 | $13,842,784 | September 30, 2021 | August 31, 2027 | KUCHEL, GEORGE A | reporter.nih.gov |
| A Tolerance Approach to Xenotransplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $13,161,555 | September 15, 2000 | December 31, 2026 | SYKES, MEGAN | reporter.nih.gov |
| Targeting the B Cell Response to Treat Antibody-Mediated Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,789,092 | August 20, 2021 | May 31, 2028 | KNECHTLE, STUART JOHNSTON | reporter.nih.gov |
| Advancing Transplantation Outcomes in Children | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,293,854 | July 1, 2025 | June 30, 2028 | BRISCOE, DAVID M. | reporter.nih.gov |
| Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,920,671 | September 6, 2021 | June 30, 2028 | BOIKE, JUSTIN | reporter.nih.gov |
| Continuation of the Chronic Renal Insufficiency Cohort (CRIC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $10,035,734 | September 28, 2001 | June 30, 2028 | DEMBER, LAURA M | reporter.nih.gov |
| Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $9,739,425 | September 1, 2022 | April 30, 2027 | GLADWIN, MARK T | reporter.nih.gov |
| dkNET Coordinating Unit: Harnessing the Power of AI and Data Science forCollaborative Discovery and Sharing in the DK Community | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $8,645,871 | December 1, 2012 | February 28, 2029 | GRETHE, JEFFREY S. | reporter.nih.gov |
| Central Hub for Kidney Precision Medicine | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $8,599,999 | September 20, 2022 | June 30, 2024 | HIMMELFARB, JONATHAN | reporter.nih.gov |
| Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. Coli Infection (HIKO STEC): A Multinational, Embedded, Cluster, Crossover, Randomized Trial | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,451,589 | September 17, 2021 | August 31, 2027 | FREEDMAN, STEPHEN BRADLEY | reporter.nih.gov |
| Central Hub for Kidney Precision Medicine | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $8,320,420 | July 1, 2024 | June 30, 2027 | HIMMELFARB, JONATHAN | reporter.nih.gov |
| KPMP Kidney Mapping and Atlas Project (KMAP) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $8,070,448 | September 20, 2022 | June 30, 2027 | KRETZLER, MATTHIAS | reporter.nih.gov |
| Phosphate binder therapy and chronic kidney disease in children | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,929,421 | June 15, 2020 | April 30, 2026 | SALUSKY, ISIDRO B. | reporter.nih.gov |
| A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients (THINKER-NEXT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,767,541 | April 15, 2021 | March 31, 2027 | SCHAUBEL, DOUGLAS EARL | reporter.nih.gov |
| CureGN | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,684,480 | September 16, 2013 | May 31, 2029 | MARIANI, LAURA H | reporter.nih.gov |
| Application of Progenitor Niche Signals to Ex Vivo Nephrogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,389,413 | September 15, 2021 | June 30, 2027 | OXBURGH, LEIF | reporter.nih.gov |
| Chronic Kidney Diseases of Uncertain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - SDCC | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,361,594 | August 25, 2021 | June 30, 2028 | LEBOV, JILL | reporter.nih.gov |
| Strategies to Optimize Pig-to-Primate Kidney Xenograft Survival | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $7,360,026 | July 1, 2016 | June 30, 2030 | ADAMS, ANDREW B | reporter.nih.gov |
| The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE) | NIH | National Institute on Aging | 2021 to 2024 | $6,976,066 | July 1, 2020 | June 30, 2025 | CHENG, SUSAN | reporter.nih.gov |
| The Kidney Disease in Children Data Management and Analysis Center (KIDMAC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,688,610 | September 30, 2003 | July 31, 2028 | NG, DEREK K | reporter.nih.gov |
| Novel therapy for alcoholic liver disease-associated hepatorenal syndrome | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $6,485,223 | September 25, 2021 | August 31, 2027 | SUBRAMANIAN, MANI | reporter.nih.gov |
| Chronic Kidney Disease in Children (CKiD) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,446,814 | September 30, 2003 | July 31, 2028 | FURTH, SUSAN L. | reporter.nih.gov |
| MAINTENANCE AND UPDATE OF THE UNITED STATES RENAL DATA SYSTEM (USRDS) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $6,205,213 | March 8, 2022 | March 7, 2024 | JOHANSEN, KIRSTEN | reporter.nih.gov |
| Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $5,901,662 | August 15, 2020 | May 31, 2026 | POLLAK, MARTIN R. | reporter.nih.gov |
| Treat-to-Target Serum Urate versus Treat-to-Avoid Symptoms in Gout: A Randomized Controlled Trial (TRUST) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $5,795,791 | September 1, 2023 | July 31, 2028 | CHOI, HYON K | reporter.nih.gov |
| A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS Trial | NIH | National Institute on Aging | 2021 to 2025 | $5,580,574 | September 1, 2021 | August 31, 2027 | MUREA, MARIANA | reporter.nih.gov |
| Chronic Kidney Disease in Children (CKiD V) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $5,467,374 | September 30, 2003 | July 31, 2028 | WARADY, BRADLEY ALAN | reporter.nih.gov |
| The Columbia PCC for CureGN: the Cure Glomerulonephropathy network | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $5,398,076 | September 16, 2013 | May 31, 2029 | BOMBACK, ANDREW STEPHEN | reporter.nih.gov |
| Kidney Transplantation from Donors with HIV: Impact on Rejection and Long-term Outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $5,224,210 | May 25, 2023 | April 30, 2028 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| CureGN-Penn PCC | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $5,209,008 | September 16, 2013 | May 31, 2029 | HOLZMAN, LAWRENCE B. | reporter.nih.gov |
| IGNITE EP2 - Admin Supplement | NIH | National Human Genome Research Institute | 2021 to 2024 | $5,199,656 | July 1, 2024 | June 30, 2025 | CAVALLARI, LARISA HUMMA | reporter.nih.gov |
| A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $5,162,956 | March 25, 2022 | February 28, 2027 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| Safety and efficacy of Belatacept in heart transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $5,158,955 | June 6, 2023 | March 31, 2028 | HABAL, MARLENA | reporter.nih.gov |
| Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $5,148,251 | March 21, 2022 | December 31, 2026 | BUYON, JILL P | reporter.nih.gov |
| Immune Cells and Secretory Pathways Leading to Human Systemic Autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,112,288 | May 1, 2019 | April 30, 2029 | PASCUAL, MARIA VIRGINIA | reporter.nih.gov |
| Cardiorenal and Metabolic Diseases Research Center | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $5,037,364 | September 5, 2013 | April 30, 2023 | HALL, JOHN E | reporter.nih.gov |
| Composite porcine islet-kidney xenotransplants to cure diabetes and renal failure | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $5,035,116 | May 21, 2020 | April 30, 2026 | SACHS, DAVID H | reporter.nih.gov |
| Preventing Cognitive Decline by Reducing BP Target Trial (PCOT) | NIH | National Institute on Aging | 2021 to 2024 | $4,956,317 | September 1, 2020 | August 31, 2025 | VAZQUEZ, MIGUEL A | reporter.nih.gov |
| The von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer: Insights into Oxygen Sensing and Treating Cancers Caused by Undruggable Mutations | NIH | National Cancer Institute | 2021 to 2025 | $4,888,860 | September 1, 2016 | August 31, 2030 | KAELIN, WILLIAM G. | reporter.nih.gov |
| 14/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Scientific Data Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,865,046 | September 25, 2017 | May 31, 2028 | FREEDMAN, BARRY IRA | reporter.nih.gov |
| Central Coordinating Site for the Polycystic Kidney Disease (PKD) Research Core Centers | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,824,202 | July 20, 2020 | August 31, 2030 | WATNICK, TERRY J | reporter.nih.gov |
| HOPE in Action: A clinical trial of HIV-to-HIV deceased donor kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $4,782,581 | August 31, 2021 | July 31, 2023 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $4,768,587 | July 15, 2022 | April 30, 2027 | BRUNNER, HERMINE I | reporter.nih.gov |
| Metabolic Influences on Complex Tumor Neighborhoods | NIH | National Cancer Institute | 2021 to 2025 | $4,722,150 | August 1, 2017 | July 31, 2030 | SIMON, M. CELESTE | reporter.nih.gov |
| UAB National Coordinating Center for the George M. O'Brien Kidney National Resource Centers | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $4,709,848 | September 1, 2023 | June 30, 2028 | ANDERSON, AMANDA HYRE | reporter.nih.gov |
| Maryland Polycystic Kidney Disease Research Core Center (MPKD-RCC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,654,991 | August 24, 2020 | August 31, 2030 | WATNICK, TERRY J | reporter.nih.gov |
| Nephrotic Syndrome Rare Disease Clinical Research Network III | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $4,641,008 | September 8, 2009 | June 30, 2025 | KRETZLER, MATTHIAS | reporter.nih.gov |
| Bcl-2 and Mcl-1 inhibition for induction of hematopoietic chimerism and renal allograft tolerance without myelosuppression in nonhuman primates | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,613,595 | June 3, 2022 | May 31, 2027 | KAWAI, TATSUO | reporter.nih.gov |
| CUREGN 3.0 - Pediatric Nephrology Consortium - PCC | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,521,564 | September 16, 2013 | May 31, 2029 | SMOYER, WILLIAM E | reporter.nih.gov |
| Glomerular Cell-Cell Crosstalk and Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,466,349 | September 3, 2013 | September 2, 2029 | DAEHN, ILSE SOFIA | reporter.nih.gov |
| Regulation of Cell Fate during Kidney Development and Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,360,112 | September 21, 2012 | August 31, 2027 | GOMEZ, ROBERTO ARIEL | reporter.nih.gov |
| UAB Childhood Cystic Kidney Disease Center (UAB-CCKDC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,330,298 | July 20, 2020 | August 31, 2030 | YODER, BRADLEY K. | reporter.nih.gov |
| Improving Medical Decision Making for Older Patients with End Stage Renal Disease | NIH | National Institute on Aging | 2021 to 2022 | $4,302,933 | April 15, 2020 | August 31, 2022 | PAASCHE-ORLOW, MICHAEL | reporter.nih.gov |
| CureGN-3: UNCPCC | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,280,738 | September 16, 2013 | May 31, 2029 | FALK, RONALD J | reporter.nih.gov |
| The Pittsburgh Scientific and Data Research Center for the COPE-AKI Consortium (Pitt-SDRC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,268,975 | July 19, 2021 | June 30, 2028 | ABEBE, KALEAB Z | reporter.nih.gov |
| Cardiorenal Genomics for Risk Prediction in African Descent Populations | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,261,183 | September 1, 2021 | August 31, 2028 | IRVIN, MARGUERITE R | reporter.nih.gov |
| Improving Medical Decision Making for Older Patients with End Stage Renal Disease | NIH | National Institute on Aging | 2023 to 2025 | $4,182,158 | April 15, 2020 | March 31, 2027 | PAASCHE-ORLOW, MICHAEL | reporter.nih.gov |
| Manganese Based MRI Contrast Agent | NIH | National Cancer Institute | 2023 to 2024 | $4,050,000 | June 5, 2023 | May 31, 2026 | HOFFMAN, VERA | reporter.nih.gov |
| Integrated spatial interrogation of cellular and molecular signatures of human kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $4,049,896 | September 15, 2017 | June 30, 2027 | DAGHER, PIERRE C | reporter.nih.gov |
| Elucidating Genetic and Environmental Second Hits in Racial and Ethnic Minorities with APOL1 High-Risk Genotypes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,038,926 | December 14, 2020 | November 30, 2026 | NADKARNI, GIRISH NITIN | reporter.nih.gov |
| Molecular and Cellular Mechanisms of the Lysosomal Storage Disease Cystinosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,910,982 | August 9, 2017 | May 30, 2027 | CATZ, SERGIO DANIEL | reporter.nih.gov |
| NRSA Training Core | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $3,908,456 | September 1, 2023 | June 30, 2028 | HSU, CHI-YUAN | reporter.nih.gov |
| In vivo Pathway Discovery in Autosomal Dominant Polycystic Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $3,867,356 | September 9, 2019 | June 30, 2025 | SOMLO, STEFAN | reporter.nih.gov |
| Discovery Science Collaborative for CKDu | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,815,468 | August 25, 2021 | June 30, 2028 | BHALLA, VIVEK | reporter.nih.gov |
| The role of hypoxia in venous neointimal hyperplasia in hemodialysis grafts | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,815,411 | February 1, 2010 | April 30, 2028 | MISRA, SANJAY | reporter.nih.gov |
| Contact Pathway Inhibitor to Prevent Vascular Access Failure | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,810,461 | June 1, 2023 | March 31, 2027 | LORENTZ, CHRISTINA U | reporter.nih.gov |
| Role of NLRP3 signals in ischemia/reperfusion-induced organ injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,795,629 | September 24, 2021 | June 30, 2026 | MCKAY, DIANNE B | reporter.nih.gov |
| Home Blood Pressure in Hemodialysis (HOME-BP) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,791,550 | May 1, 2021 | April 30, 2027 | BANSAL, NISHA | reporter.nih.gov |
| The Southeastern Acute Kidney Injury (SEAK) Alliance for the COPE-AKI Consortium | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,764,108 | July 19, 2021 | June 30, 2028 | SIEW, EDWARD D | reporter.nih.gov |
| Single cell multiomic and spatial atlas of acute and chronic kidney injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,761,289 | September 15, 2017 | June 30, 2027 | JAIN, SANJAY | reporter.nih.gov |
| Biomarker-Based Diagnostic Algorithms To Prevent, Detect And Guide Treatment Of Kidney Disease In Persons Living With HIV | NIH | National Institute on Aging | 2021 to 2025 | $3,746,708 | September 1, 2010 | May 31, 2027 | SHLIPAK, MICHAEL G | reporter.nih.gov |
| Studies on the structure of basement membranes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,732,265 | September 1, 1986 | June 30, 2029 | HUDSON, BILLY GERALD | reporter.nih.gov |
| Advanced Kidney Health Monitoring in Persons Hospitalized with Heart Failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,723,036 | September 30, 2021 | April 30, 2027 | ESTRELLA, MICHELLE M | reporter.nih.gov |
| Clinical Trial to Demonstrate Impact of an AI-enabled 3D Ultrasound-based Guidance System in Reducing Arteriovenous Fistula Cannulation Injury and Improving Patient Quality of Life | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,709,998 | September 15, 2021 | July 31, 2026 | KANG, XIN | reporter.nih.gov |
| Multiple Chronic COnditions: MultiPle dAta SouRcEs (MC COMPARE) | NIH | National Institute on Aging | 2023 to 2025 | $3,665,706 | September 1, 2023 | May 31, 2027 | DORR, DAVID A. | reporter.nih.gov |
| WNK-SPAK signaling in the Distal Nephron | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,612,246 | September 15, 2012 | May 31, 2027 | DELPIRE, ERIC J | reporter.nih.gov |
| Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana. | NIH | National Human Genome Research Institute | 2021 to 2024 | $3,584,747 | September 19, 2018 | June 30, 2025 | SKAAR, TODD C. | reporter.nih.gov |
| Social Determinants of Health, Resilience, and Premature Cognitive Aging in End-stage Renal Disease | NIH | National Institute on Aging | 2022 to 2025 | $3,570,845 | July 15, 2022 | March 31, 2027 | MCADAMS DEMARCO, MARA A. | reporter.nih.gov |
| 1/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $3,567,710 | May 15, 2019 | August 31, 2022 | GLADWIN, MARK T | reporter.nih.gov |
| PERSISTENCE OF IMMUNE RESPONSES TO THE RECOMBINANT ZOSTER VACCINE IN IMMUNE COMPROMISED HOSTS WITH END-STAGE RENAL DISEASE WITH AND WITHOUT KIDNEY TRANSPLANTATION | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,559,912 | March 6, 2019 | February 28, 2029 | WEINBERG, ADRIANA | reporter.nih.gov |
| Platform for Extended Kidney Preservation Via Subnormothermic Perfusion | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $3,527,840 | September 20, 2024 | December 31, 2026 | KOPPARTHY, VARUN LINGAIAH | reporter.nih.gov |
| JAK-STAT Inhibition to Reduce Racial Disparities in Kidney Disease | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $3,524,489 | September 20, 2021 | May 31, 2027 | OLABISI, OPEYEMI AYODEJI | reporter.nih.gov |
| PROMPT BOLUS admin supplement | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $3,504,025 | September 11, 2020 | August 31, 2026 | BALAMUTH, FRANCES B | reporter.nih.gov |
| Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial Network | NIH | National Human Genome Research Institute | 2021 to 2024 | $3,458,289 | July 1, 2024 | June 30, 2025 | PETERSON, JOSEPH F. | reporter.nih.gov |
| National Institute of Diabetes and Digestive and Kidney Diseases ATLAS (D2K-ATLAS) Center as an accessible, comprehensive data portfolio for renal and genitourinary development and disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $3,444,502 | September 25, 2022 | July 31, 2027 | VALERIUS, MICHAEL TODD | reporter.nih.gov |
| Preserving physical function in patients with kidney disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,428,324 | August 3, 2021 | June 30, 2026 | ABRAMOWITZ, MATTHEW K | reporter.nih.gov |
| Role of Estrogen Related Receptors in Age Related Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,419,454 | December 21, 2020 | June 30, 2029 | LEVI, MOSHE | reporter.nih.gov |
| Regulation of TLR signaling, Inflammation and Antigen Presentation by VPS33B | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,409,595 | July 1, 2021 | June 30, 2026 | PASARE, CHANDRASHEKHAR | reporter.nih.gov |
| Functional and Mechanistic Characterization of Lupus Susceptibility | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,364,935 | September 3, 2025 | August 31, 2029 | NATH, SWAPAN K. | reporter.nih.gov |
| Using Machine Learning for Early Recognition and Personalized Treatment of Acute Kidney Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,362,045 | August 1, 2021 | July 31, 2027 | KOYNER, JAY L | reporter.nih.gov |
| Multi-omic Predictors of Renal Function among HIV-infected Individuals of African Ancestry | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,355,374 | August 1, 2020 | March 31, 2026 | SUN, YAN | reporter.nih.gov |
| Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,348,311 | December 1, 2021 | November 30, 2026 | HE, JOHN CIJIANG | reporter.nih.gov |
| Mechanisms of Tubular Atrophy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,315,146 | August 1, 2005 | June 30, 2027 | SCHELLING, JEFFREY R | reporter.nih.gov |
| Integrating a culturally competent APOL1 genetic testing program into living donor evaluation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,312,983 | April 1, 2021 | March 31, 2027 | AGRAWAL, AKANSHA | reporter.nih.gov |
| Cleveland COPE-AKI Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,307,197 | July 19, 2021 | June 30, 2028 | POGGIO, EMILIO DANIEL | reporter.nih.gov |
| Post-Discharge Nephrology Follow-up for Improved Outcomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,277,840 | July 19, 2021 | June 30, 2028 | PARIKH, CHIRAG R | reporter.nih.gov |
| Activating Autophagy to Treat Uromodulin-Associated Genetic Chronic Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,274,015 | August 15, 2017 | August 31, 2029 | CHEN, YING MAGGIE | reporter.nih.gov |
| Sit Less, Interact and Move More (SLIMM) 2 Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,273,066 | May 15, 2021 | April 30, 2027 | BEDDHU, SRINIVASAN | reporter.nih.gov |
| Role of Mitochondrial Dysfunction in the Response to Exercise in Patients with Advanced Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,263,477 | September 20, 2021 | July 31, 2027 | IKIZLER, TALAT ALP | reporter.nih.gov |
| Spatial Multi-Omics to Profile Metabolic Pathways for Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,262,314 | September 15, 2017 | June 30, 2027 | SHARMA, KUMAR | reporter.nih.gov |
| Hepcidin-Ferroportin-Iron Axis in Cardiac Surgery-associated Acute Kidney Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,251,509 | July 15, 2022 | May 31, 2026 | LEAF, DAVID EVAN | reporter.nih.gov |
| Physical Activity/Physical Function and Longitudinal Changes in Cognitive Function in Adults with Chronic Kidney Disease. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,241,926 | September 15, 2021 | May 31, 2027 | ISAKOVA, TAMARA | reporter.nih.gov |
| Impact of metabolic acidosis on muscle mitochondrial energetics, metabolic health and physical endurance in persons with chronic kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,236,031 | August 18, 2021 | June 30, 2027 | ROSHANRAVAN, BABACK | reporter.nih.gov |
| (MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKI | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,228,490 | June 1, 2021 | March 31, 2027 | KANE-GILL, SANDRA L | reporter.nih.gov |
| Targeting innate immunity for induction of robust renal allograft tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,224,166 | July 25, 2023 | April 30, 2028 | KAWAI, TATSUO | reporter.nih.gov |
| Genetic and Functional Analysis of Rapid Renal Decline in Diabetes: A Family-based Approach to Accelerate Gene Discovery | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,206,577 | May 1, 2021 | April 30, 2027 | PEZZOLESI, MARCUS GUY | reporter.nih.gov |
| USDHub: community resource for Urinary Stone Disease research | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $3,202,605 | August 22, 2024 | May 31, 2026 | HSI, RYAN | reporter.nih.gov |
| Cell specific delivery of novel therapies to enhance glomerular regeneration and repair | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,199,320 | September 1, 2020 | May 31, 2025 | SHANKLAND, STUART JAMES | reporter.nih.gov |
| Early myocardial remodeling and progressive kidney function decline in type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,199,007 | December 24, 2021 | November 30, 2026 | DORIA, ALESSANDRO | reporter.nih.gov |
| Predicting Progression of Chronic Kidney Disease in Sickle Cell Anemia Using Machine Learning Models (PREMIER) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,193,450 | September 10, 2021 | August 31, 2026 | ATAGA, KENNETH I | reporter.nih.gov |
| Immunomodulation in AAV gene therapy | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,192,404 | August 21, 2025 | July 31, 2029 | ASOKAN, ARAVIND | reporter.nih.gov |
| Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Biostatistics Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 | $3,184,520 | August 15, 2012 | June 30, 2025 | BRAFFETT, BARBARA HALINA | reporter.nih.gov |
| Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,177,458 | January 1, 2017 | June 30, 2027 | PARK, JEANIE | reporter.nih.gov |
| Intrarenal B cells in acute kidney allograft rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,165,260 | February 15, 2020 | January 31, 2026 | CHONG, ANITA S | reporter.nih.gov |
| Translating Hyperpolarized 13C Metabolic MRI to Predict Renal Tumor Aggressiveness | NIH | National Cancer Institute | 2021 to 2025 | $3,165,143 | January 1, 2021 | December 31, 2025 | WANG, ZHEN JANE | reporter.nih.gov |
| Ex Vivo Generation of Functional Kidney Tissues for Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,161,308 | September 1, 2020 | May 14, 2025 | LEWIS, JENNIFER A. | reporter.nih.gov |
| Applying Hypertension Clinical Trials to Real World Adults with CKD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,151,118 | September 24, 2021 | May 31, 2027 | KURELLA TAMURA, MANJULA | reporter.nih.gov |
| Structure-based strategy for developing inhibitors of the kidney chloride channel CLC-Ka | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,136,050 | September 20, 2021 | March 31, 2027 | MADUKE, MERRITT C | reporter.nih.gov |
| Complement regulates macrophage and platelet function in kidney transplants | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,127,980 | September 17, 2021 | August 31, 2026 | BALDWIN, WILLIAM M | reporter.nih.gov |
| Particulate exposure and kidney health | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $3,126,986 | March 1, 2021 | December 31, 2026 | ADGATE, JOHN L. | reporter.nih.gov |
| Cardiovascular Risk, Vascular and Kidney Damage in COVID-19 Survivors | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,114,564 | January 20, 2022 | December 31, 2026 | CHIRINOS MEDINA, JULIO ALONSO | reporter.nih.gov |
| Evaluation of the Mechanisms Underlying Induction and Maintenance Immunosuppression Impact on T Cell Function after Kidney Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,106,301 | July 16, 2025 | June 30, 2029 | SCHAENMAN, JOANNA M | reporter.nih.gov |
| Crosstalk Between Lipid Droplets and Other Organelles in Podocytes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,102,617 | September 5, 2025 | September 4, 2029 | FORNONI, ALESSIA | reporter.nih.gov |
| ADPKD: Disease Spectrum & Genotype-Phenotype Correlations | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,092,802 | August 1, 2001 | May 31, 2028 | HARRIS, PETER C. | reporter.nih.gov |
| High Salt Remodels Renal Cortical and Proximal Tubular Metabolism: Metabolic Fuels, Oxidative Stress, and Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,089,494 | January 1, 2021 | November 30, 2028 | COWLEY, ALLEN W | reporter.nih.gov |
| Structure and Function of Integrins in the Kidney | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,078,830 | June 1, 2010 | March 31, 2027 | ARNAOUT, M. AMIN | reporter.nih.gov |
| HiLo Competitive Renewal | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,076,329 | August 1, 2018 | April 30, 2025 | CHAKRABORTY, HRISHIKESH | reporter.nih.gov |
| Animal Models for Studying the Genetics of Complex Diseases | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,068,389 | September 30, 1992 | December 31, 2026 | MAEDA, NOBUYO | reporter.nih.gov |
| Ferumoxytol-Enhanced Cardiac MRI for Ischemic Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,066,463 | July 1, 2020 | June 30, 2026 | NGUYEN, KIM-LIEN T | reporter.nih.gov |
| NAVIGATE Kidney: A Multi-Level Intervention to Reduce Kidney Health Disparities | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $3,050,402 | September 1, 2023 | June 30, 2028 | CERVANTES, LILIA | reporter.nih.gov |
| The Effects Of Telemedicine on Health Outcomes, Costs, and Perceptions of Care Delivery in In-Center Hemodialysis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,038,882 | May 20, 2021 | April 30, 2027 | ERICKSON, KEVIN | reporter.nih.gov |
| Unrecognized Primary Aldosteronism as a Pathogenic Mechanism for Chronic Kidney Disease in Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,037,827 | April 1, 2018 | May 31, 2029 | VAIDYA, ANAND | reporter.nih.gov |
| Acute Antibody Mediated Kidney Allograft Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,037,635 | September 17, 2021 | August 31, 2026 | FAIRCHILD, ROBERT L | reporter.nih.gov |
| Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,033,785 | June 1, 2020 | May 31, 2025 | LEBENSBURGER, JEFFREY D | reporter.nih.gov |
| New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,023,587 | September 15, 2022 | June 30, 2027 | KASKEL, FREDERICK JEFFREY | reporter.nih.gov |
| Mechanisms of alloantibody production following renal transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,014,441 | February 22, 2021 | January 31, 2027 | VALUJSKIKH, ANNA | reporter.nih.gov |
| Mitoprotective therapies for kidney injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $3,010,432 | September 15, 2025 | August 31, 2029 | BAJWA, AMANDEEP | reporter.nih.gov |
| Immune Mechanisms of Salt-Sensitive hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,002,912 | May 4, 2021 | April 30, 2026 | KIRABO, ANNET | reporter.nih.gov |
| Antithrombotic Protein C Activator for Hemodialysis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,997,175 | May 15, 2019 | April 30, 2025 | TUCKER, ERIK IAN | reporter.nih.gov |
| Comprehensive Liquid Biomarkers to Personalize Therapy in Renal Cell Carcinoma | NIH | National Cancer Institute | 2025 | $2,984,495 | September 23, 2025 | August 31, 2029 | MCKAY, RANA RAMZI | reporter.nih.gov |
| Mechanisms driving acute and chronic kidney function decline after immune checkpoint inhibitor therapy for cancer | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,974,380 | May 1, 2022 | April 30, 2027 | SISE, MEGHAN E. | reporter.nih.gov |
| Genetic, Environmental & Histologic Basis for Kidney Disease Risk among Persons Living with HIV | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,973,070 | September 1, 2018 | December 1, 2024 | LOCKE, JAYME ELIZABETH | reporter.nih.gov |
| Novel role of urinary urate in renal cystogenesis and water regulation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,967,657 | September 1, 2025 | August 31, 2029 | CHEBIB, FOUAD T | reporter.nih.gov |
| Multilevel Time-Dynamic Modeling of Hospitalization and Survival in Patients on Dialysis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,964,247 | September 15, 2011 | February 28, 2027 | SENTURK, DAMLA | reporter.nih.gov |
| The role of Vpr-mediated cell cycle dysregulation in HIV-associated kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,963,815 | August 15, 2022 | July 31, 2027 | LEE, KYUNG | reporter.nih.gov |
| Defining the Landscape of HLA Risk Alleles in Primary Nephrotic Syndrome and Post Kidney Transplant Recurrence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,958,614 | June 1, 2020 | May 31, 2026 | GBADEGESIN, RASHEED ADEBAYO | reporter.nih.gov |
| The NINOS cohort: Children's Kidney Health in a High-Risk Region for CKDu | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,955,198 | April 1, 2021 | January 31, 2027 | LEIBLER, JESSICA H | reporter.nih.gov |
| Kidney transplant Preemptive therapy or Prophylaxis (KPoP) for CMVPreventionin D+R- Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,952,999 | July 12, 2024 | May 31, 2031 | LIMAYE, ABHIJIT PRAKASH | reporter.nih.gov |
| Autocrine and paracrine podocyte signals decrease glomerular function/health in aged kidneys | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,941,810 | September 15, 2022 | June 30, 2027 | SHANKLAND, STUART JAMES | reporter.nih.gov |
| Exosomes and the Immune Response in Allograft Outcomes in Pediatric Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,938,841 | May 10, 2022 | June 30, 2024 | KRAMS, SHERI M. | reporter.nih.gov |
| Single-cell analysis to promote kidney repair | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,938,759 | September 1, 2020 | May 31, 2025 | HUMPHREYS, BENJAMIN D. | reporter.nih.gov |
| Improving Kidney Function Assessment in Health and Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,938,528 | December 15, 2020 | November 30, 2025 | INKER, LESLEY ANN | reporter.nih.gov |
| Mechanisms of diuretic resistance in heart failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,937,826 | June 1, 2022 | May 31, 2027 | TESTANI, JEFFREY M | reporter.nih.gov |
| Investigation of the role of epithelial-mesenchymal plasticity in renal cell carcinoma | NIH | National Cancer Institute | 2021 to 2025 | $2,937,308 | April 1, 2021 | March 31, 2026 | GENOVESE, GIANNICOLA | reporter.nih.gov |
| Biomarkers for acute interstitial nephritis in humans | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,934,865 | June 1, 2021 | May 31, 2027 | MOLEDINA, DENNIS G. | reporter.nih.gov |
| Statistical Methods for Kidney Markers as Shared Determinants of Dementia and Physical Disability in Older Adults | NIH | National Institute on Aging | 2022 to 2025 | $2,933,313 | September 30, 2015 | June 30, 2028 | SHARDELL, MICHELLE DENISE | reporter.nih.gov |
| T-cell depletion and maintenance of the HIV-1 latent reservoir in distinct tissue compartments | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,927,774 | April 1, 2022 | March 31, 2027 | TOBIAN, AARON A | reporter.nih.gov |
| Computational Pathology of Proteinuric Diseases | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,923,266 | August 3, 2018 | July 31, 2026 | BARISONI, LAURA MARIACHIARA | reporter.nih.gov |
| Complement in Pathogenesis and Experimental Therapy of ANCA Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,919,656 | July 1, 2020 | June 30, 2025 | SONG, WENCHAO | reporter.nih.gov |
| RIGERR: Resources for Investigating Genetic and Epigenetic Regulation of Renal Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,915,414 | August 3, 2023 | July 31, 2027 | LIANG, MINGYU | reporter.nih.gov |
| ABIN1 dysfunction in Lupus Nephritis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,909,013 | September 1, 2021 | June 30, 2027 | POWELL, DAVID W. | reporter.nih.gov |
| NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,907,004 | July 1, 2020 | June 30, 2026 | POYAN MEHR, ALI | reporter.nih.gov |
| Depleting autoantibodies for the treatment of autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,898,618 | March 11, 2022 | February 28, 2027 | KANNANGANAT SIDHARTHAN, SUNIL | reporter.nih.gov |
| Training Core | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,893,038 | September 1, 2024 | May 31, 2029 | GREKA, ANNA | reporter.nih.gov |
| A Testing Program to Identify Novel Agents for Treatment of Pediatric and AYA High-Risk Sarcoma, Kidney and Liver Cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,862,121 | September 1, 2021 | June 30, 2026 | KURMASHEVA, RAUSHAN | reporter.nih.gov |
| Precision Dosing for Critically Ill Children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,860,284 | August 17, 2022 | April 30, 2027 | NEELY, MICHAEL N. | reporter.nih.gov |
| Determinants of T Cell Fate in Transplantation Tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,859,856 | August 1, 2022 | July 31, 2027 | FORD, MANDY L | reporter.nih.gov |
| Innovations in Shock Wave Lithotripsy Technology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,856,681 | September 10, 1997 | March 31, 2027 | ZHONG, PEI | reporter.nih.gov |
| Early-Stage Preclinical Validation of Carbon Monoxide Prodrugs for Acute Kidney Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,842,625 | July 15, 2022 | June 30, 2027 | WANG, BINGHE | reporter.nih.gov |
| Maximizing The Benefit of Therapy in CKD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,842,256 | August 1, 2018 | May 31, 2027 | GRAMS, MORGAN ERIKA | reporter.nih.gov |
| The Laminin Receptors in Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,841,917 | March 1, 2005 | June 30, 2028 | ZENT, ROY | reporter.nih.gov |
| Tissue-based biomarkers of anti-PD-1-based therapy in metastatic renal cell carcinoma | NIH | National Cancer Institute | 2022 to 2025 | $2,841,134 | July 1, 2022 | June 30, 2027 | CHOUEIRI, TONI | reporter.nih.gov |
| Renal Metabolism in AKI | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,833,514 | September 15, 2025 | September 14, 2029 | SINGH, PRABHLEEN | reporter.nih.gov |
| Developmental Origins of Kidney Function in Early Life and Environmental Risks | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $2,813,545 | September 2, 2020 | June 30, 2026 | TRASANDE, LEONARDO | reporter.nih.gov |
| Characterization of Renal Allograft Fibrosis and Prediction of Outcome Using a Quantitative MRI Approach | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,812,749 | July 8, 2021 | April 30, 2027 | LEWIS, SARA C | reporter.nih.gov |
| NIMBLE: Non-Invasive Markers of Bladder Deterioration | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,811,323 | September 6, 2021 | June 30, 2027 | LEE, RICHARD SANG-YONG | reporter.nih.gov |
| Manipulating the matrix to improve arteriovenous fistula patency | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,808,984 | September 1, 2019 | August 2, 2025 | DARDIK, ALAN | reporter.nih.gov |
| Kidney Support in Pediatric Patients using an Ultrafiltration Device | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,808,664 | May 18, 2021 | July 31, 2028 | KNUESEL, ROBERT J | reporter.nih.gov |
| Deferoxamine for the Prevention of Acute Kidney Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,806,544 | September 1, 2020 | June 30, 2025 | LEAF, DAVID EVAN | reporter.nih.gov |
| Dynamic Longitudinal Functional Models with Applications to the CRIC Study | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,806,232 | April 1, 2022 | March 31, 2027 | GUO, WENSHENG | reporter.nih.gov |
| Inspiratory muscle strength training for lowering systolic blood pressure in midlife and older adults with chronic kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,803,942 | September 1, 2021 | June 30, 2027 | CHONCHOL, MICHEL BENJAMIN | reporter.nih.gov |
| Intracellular functions of APOL1 in the kidney | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,802,067 | September 23, 2021 | May 31, 2026 | BRUGGEMAN, LESLIE A | reporter.nih.gov |
| Monitoring Disease in Lupus | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,798,512 | March 8, 2019 | June 30, 2029 | MOHAN, CHANDRA | reporter.nih.gov |
| The Role of Renal Interstitium in Kidney Development | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,791,644 | July 15, 2021 | May 31, 2025 | CARROLL, THOMAS JOSEPH | reporter.nih.gov |
| Intradialytic Myocardial Stunning in Hemodialysis Patients - a Novel Cardiovascular Risk Factor | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,790,065 | December 24, 2021 | November 30, 2026 | CHARYTAN, DAVID M | reporter.nih.gov |
| Reaching Equity in ACess to Home Dialysis And Re-Transplantation (REACH-DART) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,785,676 | May 15, 2022 | February 28, 2027 | KU, ELAINE | reporter.nih.gov |
| Multi-Omics and Chronic Kidney Disease: Correlation with Histology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,783,213 | June 13, 2016 | June 30, 2027 | GRAMS, MORGAN ERIKA | reporter.nih.gov |
| The Vascular Fibroblast: An Understudied Culprit In Postoperative Venous Stenosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,777,206 | September 23, 2025 | August 31, 2029 | MARTINEZ, LAISEL | reporter.nih.gov |
| Novel Therapeutics for Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,762,670 | May 12, 2022 | August 31, 2026 | SANGARALINGHAM, SASANTHA JESON | reporter.nih.gov |
| Continuous Therapeutic Drug Monitoring of Antibiotics in CRRT | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,752,374 | February 1, 2021 | January 31, 2026 | MOHAN, SUMIT | reporter.nih.gov |
| Paneth cells-derived IL-17A and liver ischemia reperfusion injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,751,803 | July 1, 2021 | March 31, 2026 | LEE, H. THOMAS | reporter.nih.gov |
| Kidney Tubule Dysfunction and Future Risk of Acute Kidney Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,751,221 | August 19, 2021 | March 31, 2026 | IX, JOACHIM H | reporter.nih.gov |
| Blood Sugar Sensing on Maintenance Dialysis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,740,674 | August 21, 2020 | May 31, 2030 | DE BOER, IAN H | reporter.nih.gov |
| Automated detection of microstructural features that have unique protein markers and are prognostic for chronic kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,739,114 | February 10, 2011 | January 31, 2027 | RULE, ANDREW DAVID | reporter.nih.gov |
| Electronic Tools to Increase Recognition and Improve Primary Care Management for Hypertension in Chronic Kidney Disease: A Multi-site Randomized Clinical Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,737,895 | September 1, 2018 | June 30, 2030 | SAMAL, LIPIKA | reporter.nih.gov |
| Minimizing salivary gland and renal toxicity arising from PSMA-targeted alpha therapy | NIH | National Cancer Institute | 2022 to 2025 | $2,733,165 | May 1, 2022 | April 30, 2027 | PILLARSETTY, NAGAVARAKISHORE | reporter.nih.gov |
| Renal AT2 Receptors in Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,730,789 | January 1, 2021 | December 31, 2025 | KELLER, SUSANNA R | reporter.nih.gov |
| Novel evidence-accumulation-driven methods for characterizing kidney stone progression | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,722,512 | March 1, 2022 | December 31, 2027 | LIU, YU-LUN | reporter.nih.gov |
| INSPIRE: INterventionS for Promoting kIdney tRansplant Empowerment | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,713,953 | September 1, 2023 | June 30, 2028 | CHAN, LILI | reporter.nih.gov |
| Causal connections between axon guidance proteins and early progressive kidney function decline in diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,713,884 | April 1, 2022 | January 31, 2027 | KROLEWSKI, ANDRZEJ S | reporter.nih.gov |
| Investigation of common disease mechanisms in nonsyndromic and syndromic PKD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,712,900 | April 15, 2002 | December 31, 2026 | HARRIS, PETER C. | reporter.nih.gov |
| Development of Prognostic Algorithms to Identify Subjects at High Risk of ESKD in Type 2 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,712,858 | September 20, 2021 | July 31, 2025 | KROLEWSKI, ANDRZEJ S | reporter.nih.gov |
| Deep South KUH Premier Research - Interdisciplinary Mentored Education (PRIME) Training Core | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,708,913 | September 1, 2023 | June 30, 2028 | POLLOCK, DAVID M | reporter.nih.gov |
| Metagenomic profiling of urinary cell-free DNA to monitor urinary tract infection after kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,705,917 | March 10, 2020 | February 28, 2026 | DE VLAMINCK, IWIJN | reporter.nih.gov |
| Efficacy of sipIT Intervention for Increasing Urine Output in Patients with Urolithiasis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,705,515 | September 15, 2020 | July 31, 2025 | CONROY, DAVID E. | reporter.nih.gov |
| Probing the role of somatic X-chromosome alterations in shaping cancer sex differences | NIH | National Cancer Institute | 2023 to 2025 | $2,705,278 | September 20, 2023 | August 31, 2028 | VISWANATHAN, SRINIVAS RAGHAVAN | reporter.nih.gov |
| Boston Chronic Kidney Disease Research Biopsy Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,699,470 | September 15, 2022 | June 30, 2027 | WAIKAR, SUSHRUT S. | reporter.nih.gov |
| Biomechanical drivers of cystogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,696,798 | September 24, 2021 | July 31, 2025 | GUSELLA, GABRIELE LUCA | reporter.nih.gov |
| Renal Therapeutic Angiogenesis Using the Novel Biologic ELP-VEGF | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $2,693,585 | April 1, 2017 | August 31, 2025 | BIDWELL, GENE LEFLORE | reporter.nih.gov |
| Pathobiology of ANCA Glomerulonephritis: Targeting Adaptive and Innate Immune Processes for Precision Therapies | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,693,358 | July 1, 2020 | May 31, 2025 | FALK, RONALD J | reporter.nih.gov |
| Soluble mediators of relapse | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,692,344 | May 1, 2021 | April 30, 2026 | CHUGH, SUMANT SINGH | reporter.nih.gov |
| Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,690,675 | June 18, 2021 | April 30, 2027 | KENDRICK, JESSICA B | reporter.nih.gov |
| Daily Caloric Restriction in Overweight and Obese Adults with ADPKD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,687,567 | July 1, 2021 | May 31, 2027 | NOWAK, KRISTEN LYNN | reporter.nih.gov |
| Multimodal Imaging Mass Spectrometry and Spatial Omics for the Human Kidney | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,683,162 | September 15, 2022 | June 30, 2027 | SPRAGGINS, JEFFREY M | reporter.nih.gov |
| Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,681,067 | January 28, 2021 | December 31, 2026 | MONTEZ RATH, MARIA | reporter.nih.gov |
| New mouse model of cisplatin-induced AKI and development of prevention therapy | NIH | National Cancer Institute | 2021 to 2025 | $2,680,156 | August 1, 2021 | July 31, 2026 | ZHAO, JIANJUN | reporter.nih.gov |
| Kidney Injury Molecule-1 in Epithelial Repair | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,678,187 | June 1, 2005 | June 30, 2027 | BONVENTRE, JOSEPH VINCENT | reporter.nih.gov |
| A comprehensive map of polycystin channel regulation and its implications in polycystic kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,672,628 | September 15, 2021 | July 31, 2025 | DELLING, MARKUS G | reporter.nih.gov |
| Advanced Development and Utilization of Assembled Aging Trajectory Files from Multiple Datasets | NIH | National Institute on Aging | 2021 to 2025 | $2,670,804 | May 1, 2021 | August 31, 2026 | JARRÍN MONTANER, OLGA F. | reporter.nih.gov |
| The role of the innate immune cell cyclooxygenase/prostaglandin system in blood pressureregulation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,667,442 | December 20, 2002 | June 30, 2028 | HARRIS, RAYMOND C. | reporter.nih.gov |
| Elucidating IgA nephropathy through Genetic Studies of IgA1 Glycosylation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,665,061 | May 1, 2009 | April 30, 2026 | GHARAVI, ALI G | reporter.nih.gov |
| T cell homing to the kidney contributes to salt retention and blood pressure regulation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,663,886 | April 10, 2019 | March 31, 2029 | MU, SHENGYU | reporter.nih.gov |
| Post-transcriptional regulation of gene expression by microRNAs in antibody-mediated rejection | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,653,376 | September 1, 2022 | July 31, 2027 | IACOMINI, JOHN J | reporter.nih.gov |
| Role of Kir4.1 in regulating NCC and ROMK in DCT | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,644,972 | September 1, 2022 | April 30, 2027 | WANG, WENHUI | reporter.nih.gov |
| Kidney Injury in Patients with Acute Decompensated Heart Failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,634,469 | July 1, 2020 | April 30, 2026 | BANSAL, NISHA | reporter.nih.gov |
| Mechanisms of HIV persistence in the kidney | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,625,751 | August 1, 2022 | July 31, 2027 | BLASI, MARIA | reporter.nih.gov |
| NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial | NIH | National Institute on Aging | 2022 to 2024 | $2,625,739 | August 1, 2022 | July 31, 2025 | BHASIN, SHALENDER | reporter.nih.gov |
| Nutrient Regulation of Cancer Cell Growth | NIH | National Cancer Institute | 2021 to 2025 | $2,624,404 | December 6, 2017 | January 31, 2028 | CHRISTOFK, HEATHER | reporter.nih.gov |
| Hemodynamic Effects of Positive Airway Pressure to Treat Supine Hypertension and Improve Neurogenic Orthostatic Hypotension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,620,737 | December 1, 2021 | November 30, 2026 | BIAGGIONI, ITALO | reporter.nih.gov |
| Cardiac sURgery anesthesia Best practices to reduce Acute Kidney Injury (CURB-AKI) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,617,928 | July 1, 2022 | May 31, 2027 | MATHIS, MICHAEL ROBERT | reporter.nih.gov |
| Bioengineering a novel therapeutic protein complex to minimize the effects of medical device induced hemolysis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,617,125 | January 1, 2022 | December 31, 2026 | BUEHLER, PAUL WERNER | reporter.nih.gov |
| The Impact of Diabetes on Patients with Glomerular Disease: CureGN-Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,613,461 | March 11, 2021 | January 31, 2027 | MOTTL, AMY | reporter.nih.gov |
| Finding Appropriate Subtypes in a Trial of Balanced versus nOrmaL Saline FlUid in Sepsis | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,612,604 | September 20, 2022 | July 31, 2027 | YEHYA, NADIR | reporter.nih.gov |
| Tubuloglomerular feedback response in AKI to CKD transition | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,611,140 | August 29, 2022 | April 30, 2027 | LIU, RUISHENG | reporter.nih.gov |
| Impact of Randomized Payment Incentives on Disparities in Home Dialysis and Kidney Transplantation | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,608,764 | February 9, 2022 | November 30, 2026 | TRIVEDI, AMAL N. | reporter.nih.gov |
| Cell polarity and morphogenesis in Xenopus embryos | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,595,273 | August 1, 2017 | June 30, 2027 | SOKOL, SERGEI | reporter.nih.gov |
| Epigenetic biomarkers of preeclampsia risk among mothers with chronic hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,594,931 | January 1, 2022 | December 31, 2026 | HIDALGO, BERTHA | reporter.nih.gov |
| Neutrophil plasticity in autoimmune disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,593,636 | February 10, 2020 | January 31, 2026 | MAYADAS, TANYA N | reporter.nih.gov |
| Silica Nephropathy and Chronic Kidney Disease of Unknown Etiology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,589,029 | July 7, 2020 | March 31, 2030 | BROWN, JARED MICHAEL | reporter.nih.gov |
| Mechanisms involved in podocyte damage in Alport Syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,586,175 | August 15, 2022 | May 31, 2027 | PERIN, LAURA | reporter.nih.gov |
| A functional genomics pipeline for genetic discovery in diabetic kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,573,670 | August 1, 2022 | May 31, 2027 | HIRSCHHORN, JOEL N | reporter.nih.gov |
| Role of the innate immune system in acute kidney injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,567,133 | August 5, 2013 | March 31, 2027 | HARRIS, RAYMOND C. | reporter.nih.gov |
| Chronic Antibody-Mediated Rejection of Kidney Allografts | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,566,057 | February 1, 2022 | January 31, 2027 | FAIRCHILD, ROBERT L | reporter.nih.gov |
| Best Case/Worst Case: A Multisite Randomized Clinical Trial of Scenario Planning for Patients with End-Stage Kidney Disease | NIH | National Institute on Aging | 2021 to 2024 | $2,560,965 | June 1, 2020 | February 28, 2026 | SCHWARZE, MARGARET | reporter.nih.gov |
| Increasing Live Donor Kidney Transplantation Through Video-based Education and Mobile Communication | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,560,634 | August 15, 2021 | July 31, 2025 | KAYLER, LIISE | reporter.nih.gov |
| MOVE Trial: MOtiVational Strategies to Empower African Americans to Improve Dialysis Adherence | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,557,446 | August 15, 2022 | May 31, 2027 | UMEUKEJE, EBELE M | reporter.nih.gov |
| Clonal Hematopoiesis of Indeterminate Potential in Chronic Kidney Disease Patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,555,588 | July 2, 2022 | March 31, 2027 | KELLY, TANIKA NICOLE | reporter.nih.gov |
| Therapeutic Optimization of Productive Repair After Acute Kidney Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,548,406 | September 1, 2020 | May 31, 2025 | HUKRIEDE, NEIL A | reporter.nih.gov |
| Renal Anhydramnios Fetal Therapy (RAFT) Trial | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,540,189 | April 1, 2020 | February 28, 2026 | ATKINSON, MEREDITH ANN | reporter.nih.gov |
| PREcision Medicine through IntErrogation of Rna in the kidnEy (PREMIERE) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,537,792 | September 15, 2017 | June 30, 2027 | HODGIN, JEFFREY BENTON | reporter.nih.gov |
| Impact of Clonal Hematopoiesis on the Progression of Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,534,528 | April 20, 2022 | March 31, 2026 | ROBINSON-COHEN, CASSIANNE | reporter.nih.gov |
| Chronic Kidney Disease Prognosis Consortium (CKD-PC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,534,039 | November 15, 2023 | June 30, 2028 | CORESH, JOSEF | reporter.nih.gov |
| RNA binding proteins in end-organ autoimmune pathology | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,532,453 | February 8, 2022 | January 31, 2027 | GAFFEN, SARAH L | reporter.nih.gov |
| Expanded Double Negative T cells in SLE. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,529,548 | May 1, 2010 | May 31, 2026 | TSOKOS, GEORGE C | reporter.nih.gov |
| Systems analysis of mechanisms driving response to immunotherapy in clear cell cancers | NIH | National Cancer Institute | 2022 to 2025 | $2,526,750 | September 13, 2022 | August 31, 2027 | GENTLES, ANDREW J. | reporter.nih.gov |
| Promoting Increases in Living Organ Donation via Tele-navigation (PILOT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,523,913 | April 1, 2021 | February 28, 2026 | LOCKE, JAYME ELIZABETH | reporter.nih.gov |
| Impact of Dietary Fructose and High Salt Diet on Neurocardiovascular and Renal Function | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,521,635 | April 1, 2022 | March 31, 2027 | ROSSI, NOREEN F | reporter.nih.gov |
| Hip Fracture Pathology in Chronic Kidney Disease | NIH | National Institute on Aging | 2021 to 2024 | $2,515,797 | March 1, 2020 | December 31, 2025 | HUGHES-AUSTIN, JAN MARIE | reporter.nih.gov |
| Disasters, solar energy, and chronic disease management in aging Puerto Ricans | NIH | National Institute on Aging | 2022 to 2025 | $2,513,489 | February 1, 2022 | December 31, 2026 | VARAS-DIAZ, NELSON | reporter.nih.gov |
| Combination of Novel Therapies for CKD Comorbid Depression (CONCORD) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,506,802 | April 15, 2020 | September 1, 2023 | HEDAYATI, SUSAN | reporter.nih.gov |
| Automatic Wide-Field Optical Coherence Tomography for Assessment of Transplant Kidney Viability | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,502,656 | September 15, 2022 | July 31, 2027 | ZHANG, XIAOHUI FRANK | reporter.nih.gov |
| Ontogeny of drug transport | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,502,241 | April 1, 2015 | July 31, 2026 | PRASAD, BHAGWAT | reporter.nih.gov |
| Kids CoLab - Supporting collaborative decision making with youth impacted by chronic kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,499,386 | September 1, 2022 | June 30, 2027 | POLLACK, ARI | reporter.nih.gov |
| Dietary and Microbial Reprogramming of Intestinal Microbiota-Produced Metabolites | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,496,867 | September 18, 2014 | March 31, 2026 | SONNENBURG, JUSTIN L | reporter.nih.gov |
| C3 Glomerulopathy -- A Collaborative Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,489,141 | April 1, 2017 | December 31, 2027 | SMITH, RICHARD J.H. | reporter.nih.gov |
| Podocyte-specific Rap1 agonism for treatment of glomerular disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,482,676 | April 1, 2022 | February 28, 2027 | KAUFMAN, LEWIS | reporter.nih.gov |
| Molecular Basis of Pathogenicity of IgA1-containing Immune Complexes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,480,984 | June 1, 2007 | March 31, 2028 | NOVAK, JAN | reporter.nih.gov |
| TRIO NRSA Training Core | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,479,467 | September 1, 2023 | June 30, 2028 | HOGAN, SUSAN LYNN | reporter.nih.gov |
| Novel downstream effectors of protein kinase G in hypertensive disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,476,417 | April 1, 2021 | March 31, 2026 | STELZER, JULIAN | reporter.nih.gov |
| TABA for SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaS | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,474,784 | April 15, 2020 | April 30, 2027 | BOIRE, TIMOTHY CHARLES | reporter.nih.gov |
| Organ banking for transplant--kidney cryopreservation by vitrification and novel nanowarming technology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,474,268 | April 13, 2018 | March 31, 2027 | FINGER, ERIK BRIAN | reporter.nih.gov |
| Plasminogen in glomerular disease progression | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,473,249 | July 1, 2020 | August 31, 2030 | CAMPBELL, KIRK N | reporter.nih.gov |
| Malaria associated pathogenesis of chronic kidney disease (MAP-CKD) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,470,944 | June 1, 2025 | May 31, 2027 | CONROY, ANDREA L. | reporter.nih.gov |
| AI driven acute renal replacement therapy - (AID-ART) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,468,559 | September 30, 2021 | April 30, 2026 | MURUGAN, RAGHAVAN | reporter.nih.gov |
| Polycystins, cilia, and extracellular vesicles in C. elegans | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,467,492 | May 1, 2001 | June 30, 2027 | BARR, MAUREEN M | reporter.nih.gov |
| Targeting LIGHT for treatment of glomerulonephritis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,466,907 | September 1, 2025 | August 31, 2029 | KASINATH, VIVEK | reporter.nih.gov |
| Identifying pathways required for integration of kidney organoid and host epithelia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,461,009 | September 1, 2020 | May 31, 2025 | DRUMMOND, IAIN A. | reporter.nih.gov |
| The Chorotega CKDu Epidemiology Field Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,460,606 | August 25, 2021 | June 30, 2028 | FRANCESCHINI, NORA | reporter.nih.gov |
| Advanced Diffusion Imaging for Management of Renal Cancer: Oncologic Control and Renal Functional Reserve - Resubmission - 1 | NIH | National Cancer Institute | 2021 to 2025 | $2,458,467 | August 1, 2020 | April 30, 2026 | SIGMUND, ERIC EDWARD | reporter.nih.gov |
| Role of FGF23 and Phosphate in Chronic Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,455,584 | January 1, 2022 | May 31, 2026 | MARTIN, ALINE C | reporter.nih.gov |
| Pathogenesis of Lupus Nephritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,451,240 | May 6, 2020 | April 30, 2025 | CRAFT, JOSEPH EDGAR | reporter.nih.gov |
| Role of homocysteine metabolism, endothelial function and microvascular rarefaction on renal disease severity and progression in ADPKD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,449,537 | May 1, 2021 | March 31, 2026 | IRAZABAL, MARIA V | reporter.nih.gov |
| Cognitive Decline and Incident Dementia in Older Patients with Secondary Hyperparathyroidism | NIH | National Institute on Aging | 2023 to 2025 | $2,448,340 | February 15, 2023 | January 31, 2028 | MATHUR, AARTI | reporter.nih.gov |
| Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,447,499 | July 27, 2022 | June 30, 2027 | NADEAU, KRISTEN JANE | reporter.nih.gov |
| Macrophages as modulators of T cell function and therapeutic response in clear cell renal cell carcinoma | NIH | National Cancer Institute | 2021 to 2025 | $2,442,853 | April 8, 2021 | March 31, 2026 | HAKIMI, ABRAHAM ARI | reporter.nih.gov |
| Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1 | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,442,150 | December 23, 2022 | November 30, 2027 | LEVINE, MICHAEL A. | reporter.nih.gov |
| Improving Access to Nephrology Treatment and Care among Patients at Greatest Risk for Kidney Failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,442,134 | September 1, 2023 | June 30, 2028 | ARRIOLA, KIMBERLY RUTH JACOB | reporter.nih.gov |
| Tomotherapy and Hematopoietic Stem Cells for Tolerance to Kidney Transplants | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,439,463 | August 1, 2012 | April 30, 2024 | KAUFMAN, DIXON B | reporter.nih.gov |
| The Role in OAT1 in Uremia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,431,655 | January 15, 2017 | July 31, 2026 | NIGAM, SANJAY K | reporter.nih.gov |
| New approaches to kidney banking through nature-inspired high sub-zero preservation strategies | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,410,750 | August 5, 2019 | August 31, 2026 | WEEGMAN, BRADLEY P | reporter.nih.gov |
| Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOP-CKD) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,400,751 | September 13, 2018 | August 31, 2025 | IX, JOACHIM H | reporter.nih.gov |
| Multi-Omics for Chronic Kidney Disease | NIH | National Human Genome Research Institute | 2023 to 2025 | $2,399,945 | September 12, 2023 | May 31, 2028 | KIRYLUK, KRZYSZTOF | reporter.nih.gov |
| Chronic Renal Insufficiency and Silent Progression of Aortic Stenosis (CRISP-AS) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,398,742 | July 1, 2023 | June 30, 2028 | STROM, JORDAN BLAIR | reporter.nih.gov |
| PKD proteins in endothelial cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,397,306 | February 15, 2021 | January 31, 2026 | JAGGAR, JONATHAN H | reporter.nih.gov |
| Clonal hematopoiesis, mild cognitive impairment and kidney function decline | NIH | National Institute on Aging | 2022 to 2025 | $2,396,339 | June 1, 2022 | March 31, 2027 | CHONCHOL, MICHEL BENJAMIN | reporter.nih.gov |
| Pathogenesis of kidney disease in type 1 diabetes: a modern kidney biopsy cohort | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,395,247 | May 23, 2022 | March 31, 2027 | DE BOER, IAN H | reporter.nih.gov |
| Targeting heat shock protein 72 to improve renal function after transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,394,886 | March 15, 2021 | July 31, 2026 | PARAJULI, NIRMALA | reporter.nih.gov |
| The role of the proximal nephron in salt-sensitive hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,391,475 | January 1, 2021 | June 30, 2025 | GARVIN, JEFFREY L. | reporter.nih.gov |
| Regulation of FGF23 in Chronic Kidney Disease (CKD) by iron and inflammation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,390,905 | August 1, 2015 | June 30, 2025 | DAVID, NICOLAE VALENTIN | reporter.nih.gov |
| Urine based circulating tumor DNA analysis | NIH | National Cancer Institute | 2021 to 2025 | $2,390,011 | July 1, 2021 | June 30, 2026 | LAUTENSCHLAEGER, TIM | reporter.nih.gov |
| Chronic Renal Insufficiency Cohort (CRIC) Study Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,386,972 | September 30, 2001 | June 30, 2026 | GO, ALAN S | reporter.nih.gov |
| Virtually Supervised Exercise for Kidney Transplant Candidates | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,386,134 | September 15, 2022 | August 31, 2027 | LIU, CHRISTINE KEE | reporter.nih.gov |
| Access to Kidney Transplantation in Minority Populations (AKT-MP) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $2,384,015 | July 7, 2020 | January 31, 2026 | MYASKOVSKY, LARISSA | reporter.nih.gov |
| Adipose-derived sPRR controls circadian rhythm of blood pressure through inhibition of renal NCC activity | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,378,647 | July 1, 2022 | June 30, 2027 | YANG, TIANXIN | reporter.nih.gov |
| Overcoming humoral rejection after xenotransplantation in sensitized nonhuman primate recipients | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,378,023 | February 6, 2023 | January 31, 2028 | KWUN, JEAN | reporter.nih.gov |
| Role of primary cilium-generated signaling in polycystic kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,373,193 | January 15, 2022 | November 30, 2026 | MUKHOPADHYAY, SAIKAT | reporter.nih.gov |
| Acute kidney injury and microbiome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,372,693 | July 15, 2020 | April 30, 2026 | RABB, HAMID | reporter.nih.gov |
| Real-world effectiveness of preventive pharmacological therapy for patients with kidney stones | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,372,377 | April 1, 2020 | March 31, 2026 | SHAHINIAN, VAHAKN B | reporter.nih.gov |
| Covid 19 cytokine storm | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,371,605 | August 15, 2021 | July 31, 2025 | CHUGH, SUMANT SINGH | reporter.nih.gov |
| Mechanisms of EGFR Activation and Signaling in Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,370,029 | January 1, 1997 | December 31, 2025 | HARRIS, RAYMOND C. | reporter.nih.gov |
| Effects of Expanding Medicare Advantage Enrollment toPersons with End-stage Renal Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,369,178 | June 21, 2021 | February 28, 2026 | TRIVEDI, AMAL N. | reporter.nih.gov |
| Adaptive and maladaptive repair after kidney injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,364,820 | March 1, 2007 | November 30, 2028 | SUSZTAK, KATALIN | reporter.nih.gov |
| Advancing Fluorescence Imaging-guided Partial Nephrectomy with ClearICG | NIH | National Cancer Institute | 2021 to 2024 | $2,363,386 | September 23, 2021 | August 31, 2025 | YU, MENGXIAO | reporter.nih.gov |
| Pathogenic Fiber Formation in Bacteria: Structural Basis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,362,500 | February 1, 2001 | March 31, 2026 | HULTGREN, SCOTT J. | reporter.nih.gov |
| The role of cyclin G1 and CDK5 in chronic kidney disease. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,361,628 | April 1, 2019 | May 31, 2026 | BROOKS, CRAIG ROBERT | reporter.nih.gov |
| Clonal hematopoiesis and inherited genetic variation in sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,361,205 | April 1, 2023 | March 31, 2027 | BICK, ALEXANDER | reporter.nih.gov |
| Intraflagellar Transport Proteins in Mice | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,358,960 | June 1, 2001 | January 31, 2027 | PAZOUR, GREGORY J | reporter.nih.gov |
| Cardiac dysfunction after ischemic AKI in mice | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,358,127 | May 10, 2021 | April 30, 2026 | FAUBEL, SARAH G | reporter.nih.gov |
| Kidney Stone Disease In ADPKD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,353,533 | September 22, 2021 | June 30, 2027 | CHONCHOL, MICHEL BENJAMIN | reporter.nih.gov |
| Mitigating Diabetic Ketoacidosis in People with T1D and Chronic Kidney Disease on an SGLT1&2 Inhibitor: Ketosis Risk Factor Determination and Incorporation into an Enhanced Glucose Ketone Report | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,352,906 | September 1, 2025 | August 31, 2028 | BERGENSTAL, RICHARD MAURITZ | reporter.nih.gov |
| WNK Kinase Regulation of Thiazide-sensitive NaCl Transport | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,352,644 | August 1, 1998 | May 31, 2030 | ELLISON, DAVID HOADLEY | reporter.nih.gov |
| Uric Acid, Klotho and Salt Sensitivity in Young Adults Born Preterm | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,351,177 | August 15, 2019 | July 31, 2025 | CHAPPELL, MARK C | reporter.nih.gov |
| Macrophages and attenuation of inflammation resolution in APOL1 nephropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,348,020 | May 20, 2022 | March 31, 2027 | KAPITSINOU, PINELOPI P. | reporter.nih.gov |
| Role of piezo channels in intercalated cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,346,695 | April 1, 2022 | March 31, 2027 | KLEYMAN, THOMAS R | reporter.nih.gov |
| Functional Analysis of Mrgpr Family in itch sensation | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,343,317 | February 7, 2007 | January 31, 2026 | DONG, XINZHONG | reporter.nih.gov |
| Outcomes in living kidney donors over 50 years compared to a healthy matched contemporaneous non-donor cohort from the same geographical region | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,341,803 | July 1, 2020 | April 30, 2025 | MATAS, ARTHUR J | reporter.nih.gov |
| Molecular mechanisms regulating peripheral arterial disease pathobiology in chronic kidney disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,339,606 | December 1, 2019 | November 30, 2025 | RYAN, TERENCE E | reporter.nih.gov |
| HLA Immunogenetics and kidney allograft outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,338,883 | November 21, 2022 | October 31, 2027 | KAMOUN, MALEK | reporter.nih.gov |
| UAB-UCSD O'Brien Center for Acute Kidney Injury Research | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $2,336,168 | September 1, 2008 | July 31, 2023 | AGARWAL, ANUPAM | reporter.nih.gov |
| The Synthetic Kidney: A Revolutionary Solution for the Shortage of Kidneys for Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,335,138 | September 15, 2022 | August 31, 2027 | LI, ZHONGWEI | reporter.nih.gov |
| Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems | NIH | National Center for Advancing Translational Sciences | 2022 to 2024 | $2,334,876 | July 15, 2020 | June 30, 2026 | FREEDMAN, BENJAMIN SOLOMON | reporter.nih.gov |
| PP2A as a drug target for diabetic kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,334,369 | July 21, 2020 | April 30, 2025 | HE, JOHN CIJIANG | reporter.nih.gov |
| The role of DMP1 in FGF23-induced hypophosphatemia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,327,228 | April 1, 2022 | July 31, 2026 | MARTIN, ALINE C | reporter.nih.gov |
| Modulation of cystogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,324,556 | May 1, 2022 | February 28, 2027 | ZHOU, JING | reporter.nih.gov |
| Multiphoton imaging of the juxtaglomerular apparatus | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,320,568 | February 21, 2004 | May 31, 2027 | PETI-PETERDI, JANOS | reporter.nih.gov |
| Interactions between metabolism, transport, and toxicity of benzalkonium chlorides | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,318,030 | September 10, 2021 | June 30, 2026 | XU, LIBIN | reporter.nih.gov |
| Multi-Omics at the Intersections of Environment, Diabetes, and Kidney Disease: A Multi-Omics for Health and Disease Study Site | NIH | National Human Genome Research Institute | 2023 to 2025 | $2,316,134 | September 12, 2023 | May 31, 2028 | KELLY, TANIKA NICOLE | reporter.nih.gov |
| Pax2 Interacting Proteins in Development and Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,315,507 | January 15, 1999 | May 31, 2025 | DRESSLER, GREGORY R | reporter.nih.gov |
| Integrating novel mechanisms controlling sodium excretion and blood pressure | NIH | National Heart, Lung, and Blood Institute | 2021 | $2,309,810 | May 1, 2017 | March 31, 2022 | POLLOCK, DAVID M | reporter.nih.gov |
| Hippo-YAP in podocyte health and disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,308,585 | September 3, 2019 | May 31, 2029 | CAMPBELL, KIRK N | reporter.nih.gov |
| Gut Microbiome and Cancer Immunotherapy Outcomes in Advanced Renal Cell Carcinoma | NIH | National Cancer Institute | 2022 to 2025 | $2,305,974 | March 1, 2022 | February 28, 2027 | FEDIRKO, VERONIKA | reporter.nih.gov |
| The Impact of Structural Racism on Racial/Ethnic Disparities in End-Stage Kidney Disease from Healthy Population to Mortality | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $2,304,849 | August 1, 2022 | April 29, 2025 | DAW, JONATHAN KYLE | reporter.nih.gov |
| MASPs as therapeutic targets in complement-mediated diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,302,777 | March 18, 2020 | February 28, 2025 | SONG, WENCHAO | reporter.nih.gov |
| Creating high-resolution multi-omics molecular atlases for developing urogenital organs | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,298,845 | September 30, 2021 | July 31, 2027 | CHEN, FENG | reporter.nih.gov |
| Gene Nutrient Interactions in Kidney Function | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,294,490 | December 4, 2017 | July 31, 2027 | GUDAS, LORRAINE J | reporter.nih.gov |
| Cell Cycle and Metabolism in Chronically Injured Renal Tubules | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,287,398 | June 13, 2016 | June 30, 2026 | GEWIN, LESLIE S | reporter.nih.gov |
| Redefining cardiovascular risk assessment in dialysis patients (ROCK-D) study | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,274,042 | April 1, 2023 | March 31, 2028 | LIM, KENNETH | reporter.nih.gov |
| Delivery of an At-Home Nonpharmacologic Intervention (Transcranial Neurostimulation) to Mitigate Pain in Patients with End Stage Kidney Disease Receiving Hemodialysis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,272,259 | December 1, 2021 | November 30, 2026 | REID, MANNEY CARRINGTON | reporter.nih.gov |
| SGK Regulation of Epithelial Sodium Transport | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,272,063 | August 15, 2000 | January 31, 2027 | PEARCE, DAVID | reporter.nih.gov |
| Mechanism of Renal Cortical Insulin Resistance | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,268,289 | September 1, 2022 | April 30, 2026 | SHULMAN, GERALD I | reporter.nih.gov |
| Convergent Drivers of Tumor Evolution at the Mitotic Spindle | NIH | National Cancer Institute | 2022 to 2025 | $2,265,126 | July 1, 2022 | June 30, 2027 | MASON, FRANK M | reporter.nih.gov |
| ENaC regulation and its role in blood pressure homeostasis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,265,124 | May 1, 1996 | June 30, 2029 | KLEYMAN, THOMAS R | reporter.nih.gov |
| Vaccine Targeting of RCC Blood Vessels to Promote TME Normalization and Enhance TIL Recruitment | NIH | National Cancer Institute | 2021 to 2025 | $2,260,673 | September 20, 2021 | August 31, 2026 | STORKUS, WALTER J. | reporter.nih.gov |
| Genetic Testing (APOL1) Decisional Support for Potential Living Kidney Donors | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,255,854 | September 30, 2021 | April 30, 2026 | GARDINER, HEATHER MARIE | reporter.nih.gov |
| Elucidating the Biology of Cardiovascular Risk in Hemodialysis Patients Using Proteomics | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,255,523 | August 15, 2022 | April 30, 2026 | DUBIN, RUTH | reporter.nih.gov |
| CommunityRx-Chronic Kidney Disease (CRx-CKD) in Rural North Carolina | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,244,453 | September 1, 2023 | June 30, 2028 | DAVE, GAURAV | reporter.nih.gov |
| India - Factors of CKDu in Uddanam Study (India-FOCUS) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,242,737 | August 25, 2021 | June 30, 2028 | MOHAN, SUMIT | reporter.nih.gov |
| Role of bFGF low affinity receptors in childhood HIVAN | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,237,272 | September 1, 1999 | June 30, 2027 | RAY, PATRICIO E. | reporter.nih.gov |
| Innovative Approaches to Treating Alport Syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,233,451 | September 22, 2021 | June 30, 2027 | MINER, JEFFREY H | reporter.nih.gov |
| Contributions of autophagy-related genes in lupus | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,228,235 | August 18, 2023 | July 31, 2027 | NATH, SWAPAN K. | reporter.nih.gov |
| Kids: Nocturnal Investigation into Glomerular Disease, Hypertension, and Transcriptomics (kNIGHT) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,217,113 | March 15, 2023 | February 29, 2028 | SETHNA, CHRISTINE B | reporter.nih.gov |
| Intra-graft C1 esterase inhibitor therapy for deceased kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $2,216,525 | September 1, 2024 | August 31, 2031 | HEEGER, PETER SCOTT | reporter.nih.gov |
| Intra-graft C1 esterase inhibitor therapy for deceased kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $2,216,525 | September 1, 2024 | August 31, 2031 | HEEGER, PETER SCOTT | reporter.nih.gov |
| Salt Mediated Cross Talk Between Lymphatic Vessels and Immune Cells in Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,215,581 | June 2, 2023 | April 30, 2028 | KON, VALENTINA | reporter.nih.gov |
| Integration of Geriatric Care into Dialysis Clinics | NIH | National Institute on Aging | 2025 | $2,214,990 | September 1, 2023 | August 31, 2028 | HALL, RASHEEDA K | reporter.nih.gov |
| Prospective renal insufficiency cohort evaluation: PRICE | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,211,367 | September 28, 2001 | December 31, 2026 | COHEN, DEBBIE L | reporter.nih.gov |
| Targeting Podocyte-Endothelial Cell Crosstalk as a FSGS Therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,210,367 | June 1, 2023 | March 31, 2028 | SHANKLAND, STUART JAMES | reporter.nih.gov |
| Metal mixture effects on mitochondrial dysfunction in kidney development and maturation: Towards a whole mixture risk assessment | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $2,205,756 | April 20, 2023 | March 31, 2026 | SANDERS, ALISON P | reporter.nih.gov |
| Renal electrolyte handling in females vs. males over life cycle | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,202,862 | August 1, 2010 | May 31, 2027 | MCDONOUGH, ALICIA A. | reporter.nih.gov |
| Etiology of Persistent Microalbuminuria in Nigeria | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,202,068 | July 1, 2021 | May 31, 2026 | WESTER, C. WILLIAM | reporter.nih.gov |
| Autophagy and Arteriovenous Fistula Maturation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,198,887 | June 1, 2021 | April 30, 2026 | LEE, TIMMY C | reporter.nih.gov |
| The role of MLKL in the regulation of vascular calcification in CKD | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,198,457 | June 1, 2016 | May 31, 2027 | MIYAZAKI, MAKOTO | reporter.nih.gov |
| Predictors of hemorrhage among patients on direct acting oral anticoagulants | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,194,092 | May 20, 2008 | January 31, 2026 | LIMDI, NITA A | reporter.nih.gov |
| Coordinated SLC12A3/SLC12A6/SL26A4 electroneutral transport pathways maintain K+ homeostasis and acid-base balance | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,194,019 | June 15, 2017 | May 31, 2027 | DELPIRE, ERIC J | reporter.nih.gov |
| NMR-Based Rapid Fluid Assessment: Device Design and Signal Processing | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,193,098 | May 5, 2022 | January 31, 2027 | CIMA, MICHAEL J | reporter.nih.gov |
| Innovative therapeutic approaches to treat chronic kidney disease | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $2,187,500 | September 13, 2022 | August 31, 2027 | TERKER, ANDREW S. | reporter.nih.gov |
| QT prolonging medications and sudden cardiac death among individuals on hemodialysis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,185,557 | April 1, 2020 | March 31, 2025 | FLYTHE, JENNIFER E | reporter.nih.gov |
| Improving Pediatric SPECT Imaging: Enhanced Lesion Detection with Dose Reduction through Advanced Reconstruction and Motion Correction | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2023 | $2,185,280 | June 1, 2020 | February 28, 2025 | KING, MICHAEL A | reporter.nih.gov |
| Deep learning on ECGs to improve outcomes in patients on dialysis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,181,958 | August 1, 2023 | May 31, 2028 | NADKARNI, GIRISH NITIN | reporter.nih.gov |
| The Intersection of Podocyte Disease and Aging | NIH | National Institute on Aging | 2023 to 2025 | $2,180,392 | August 15, 2023 | April 30, 2028 | SHANKLAND, STUART JAMES | reporter.nih.gov |
| Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,179,647 | August 14, 2020 | July 31, 2026 | ILATOVSKAYA, DARIA | reporter.nih.gov |
| Biochemical and functional characterization of a novel anti-inflammatory biogenic amine | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,177,069 | July 6, 2023 | June 30, 2028 | SANTAMBROGIO, LAURA | reporter.nih.gov |
| Oxalate-Driven Host Responses in Kidney Stone Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,172,481 | September 1, 2022 | May 31, 2027 | MITCHELL, TANECIA R | reporter.nih.gov |
| NPHP2 in ciliary function, renal fibrosis and cyst formation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,168,386 | September 15, 2017 | April 30, 2027 | SUN, ZHAOXIA | reporter.nih.gov |
| Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,166,435 | September 14, 2020 | May 31, 2026 | MALLIPATTU, SANDEEP K | reporter.nih.gov |
| Circulating microbiome and premature mortality in hemodialysis patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,165,649 | July 1, 2020 | February 28, 2026 | SUMIDA, KEIICHI | reporter.nih.gov |
| Modulation of VSMC phenotype through the Insulin Receptor Substrate-1/Kruppel-like factor-4 signal transduction pathway: a Novel Target for AVF Dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,165,001 | May 1, 2022 | April 30, 2027 | XI, GANG | reporter.nih.gov |
| PKD1 derepression as a potential therapy for Polycystic Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,160,777 | September 1, 2022 | May 31, 2027 | PATEL, VISHAL | reporter.nih.gov |
| An individualized medicine approach to urinary stone disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,155,309 | September 1, 2022 | November 30, 2026 | LIESKE, JOHN C | reporter.nih.gov |
| Ion Channel Function and Regulation of the Polycystin-1/2 Complex in Kidney Physiology and Polycystic Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,154,216 | July 1, 2020 | May 31, 2026 | QIAN, FENG | reporter.nih.gov |
| Innate Allorecognition in Clinical Organ Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,152,469 | December 20, 2022 | June 30, 2025 | LAKKIS, FADI G. | reporter.nih.gov |
| Dissecting and targeting lysosomal signaling in kidney tumorigenesis | NIH | National Cancer Institute | 2022 to 2025 | $2,144,296 | March 21, 2022 | February 28, 2027 | ZONCU, ROBERTO | reporter.nih.gov |
| Non-APOL1 genetic factors and kidney transplant outcomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,142,442 | August 15, 2023 | May 31, 2028 | KIRYLUK, KRZYSZTOF | reporter.nih.gov |
| Dihydroceramide Desaturase-1 Inhibitors for Treatment of Diabetes and Other Metabolic Diseases | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $2,139,998 | September 11, 2017 | August 31, 2024 | BLITZER, JEREMY | reporter.nih.gov |
| Exploring risk factors and predictors of endemic CKDu in agricultural regions of four Central America countries | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,139,703 | September 1, 2021 | June 30, 2028 | CROWE, JENNIFER | reporter.nih.gov |
| Continuation of the University of Illinois Chicago CRIC Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,138,544 | September 28, 2001 | June 30, 2027 | LASH, JAMES P. | reporter.nih.gov |
| Kidney Injury by Cisplatin and Renoprotective Strategies | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,138,289 | September 30, 2010 | June 30, 2029 | DONG, ZHENG | reporter.nih.gov |
| Role of FGF23 in Bone, Kidney, Blood, Crosstalk in Sickle Cell Disease Mice | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,133,643 | April 1, 2022 | January 31, 2027 | HURLEY, MARJA MARIE | reporter.nih.gov |
| Thrombin-Mediated Podocyte Injury Mechanisms | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,133,362 | September 22, 2021 | June 30, 2027 | KERLIN, BRYCE ANDREW | reporter.nih.gov |
| Molecular Pathobiology of Alport Syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,132,321 | September 15, 2022 | April 30, 2027 | HUDSON, BILLY GERALD | reporter.nih.gov |
| Metabolic barriers to T cell activation in clear cell renal cell carcinoma | NIH | National Cancer Institute | 2021 to 2025 | $2,128,833 | April 1, 2018 | June 30, 2025 | RATHMELL, JEFFREY C | reporter.nih.gov |
| APOL1 associated disease spectrum | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,127,345 | December 21, 2015 | July 31, 2026 | SUSZTAK, KATALIN | reporter.nih.gov |
| Endotoxin preconditioning as a model to uncover protective pathways in sepsis-induced renal injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,116,770 | August 25, 2016 | May 31, 2027 | DAGHER, PIERRE C | reporter.nih.gov |
| Monocyte chemoattractant Proteins and Vascular Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,102,067 | July 1, 2023 | April 30, 2027 | MISRA, SANJAY | reporter.nih.gov |
| Acute declines in kidney function during blood pressure interventions in CKD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,100,451 | May 1, 2020 | February 28, 2026 | KU, ELAINE | reporter.nih.gov |
| AKI Matched Phenotype Linked Evaluation with Tissue (AMPLE-Tissue) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,099,997 | September 12, 2017 | June 30, 2027 | PARIKH, CHIRAG R | reporter.nih.gov |
| Cloning and characterization of PRR24 as a specific renin receptor critically involved in vasopressin signaling in the kidney | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,092,309 | February 18, 2015 | April 30, 2027 | YANG, TIANXIN | reporter.nih.gov |
| D2 receptor variation and renal dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,089,789 | January 20, 2023 | December 31, 2027 | JOSE, PEDRO A. | reporter.nih.gov |
| Epigenetic mechanisms of gene regulation in nephron progenitor cell proliferation and differentiation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,088,471 | July 1, 2021 | June 30, 2027 | RAUCHMAN, MICHAEL I | reporter.nih.gov |
| Reaching Equity for Adults and CHildren in Transplant (REACH-TRANSPLANT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,085,721 | September 11, 2019 | June 30, 2025 | KU, ELAINE | reporter.nih.gov |
| Artificial Intelligence-based & Ethically-focused Multi-Modal Data Integration Framework for Screening, Diagnosing, and Caring for CKD Patients | NIH | Office of the Director, National Institutes of Health | 2025 | $2,084,185 | September 1, 2025 | August 31, 2026 | SARDER, PINAKI | reporter.nih.gov |
| Developing a Translation Pipeline for VHL Mutant Malignancies | NIH | National Cancer Institute | 2021 to 2025 | $2,084,051 | April 1, 2019 | March 31, 2028 | MCDERMOTT, DAVID | reporter.nih.gov |
| Chemical Exchange Saturation Transfer (CEST) MRI for the Characterization Small Renal Masses | NIH | National Cancer Institute | 2021 to 2025 | $2,083,644 | May 17, 2021 | April 30, 2026 | VINOGRADOV, ELENA | reporter.nih.gov |
| Technology Assisted Collaborative Care Implementation Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,082,502 | July 5, 2017 | May 31, 2029 | JHAMB, MANISHA | reporter.nih.gov |
| Clinical applications of urine proteomics to lupus nephritis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,082,416 | March 1, 2023 | December 31, 2027 | FAVA, ANDREA | reporter.nih.gov |
| Dimensions of Kidney Tubule Health and Atherosclerotic Cardiovascular Disease and Heart Failure in Middle-Aged and Older Adults | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,079,493 | December 25, 2022 | November 30, 2026 | SARNAK, MARK J | reporter.nih.gov |
| Blood and Urine Biomarkers for Predicting Long-Term Adverse Kidney and Cardiovascular Outcomes after Cardiac Surgery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,079,484 | May 15, 2019 | April 30, 2025 | FOX, AMANDA A | reporter.nih.gov |
| Neural and genetic mechanisms underlying behavior in C. elegans | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,075,451 | June 1, 2018 | January 28, 2026 | XU, SHAWN | reporter.nih.gov |
| CKDu in Salvadoran and Nicaraguan Agricultural Communities | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,075,171 | August 25, 2021 | June 30, 2028 | SCAMMELL, MADELEINE | reporter.nih.gov |
| Nephronophthisis-related ciliopathies and ciliary specialization | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,071,959 | February 15, 2023 | December 31, 2026 | BARR, MAUREEN M | reporter.nih.gov |
| Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD) Syndrome in the Diabetic, Neuropathic Foot | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,064,907 | March 1, 2016 | June 30, 2028 | HASTINGS, MARY K | reporter.nih.gov |
| Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,063,000 | March 1, 2020 | February 28, 2026 | GREEN, TODD JASON | reporter.nih.gov |
| Dissecting the role of dynamic epigenome prompting pathways leading to kidney allograft fibrosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,062,322 | July 1, 2019 | June 30, 2025 | MAS, VALERIA RAQUEL | reporter.nih.gov |
| Effect of Renal Nerves on Chronic Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,060,887 | June 1, 2022 | March 31, 2027 | TAN, RODERICK JASON | reporter.nih.gov |
| University of Illinois at Chicago KPMP CKD Recruitment Site | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,059,531 | September 15, 2022 | June 30, 2027 | LASH, JAMES P. | reporter.nih.gov |
| Manganese-based Contrast Agent for Cardiovascular MRI | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $2,057,361 | December 15, 2020 | May 31, 2026 | HOFFMAN, VERA | reporter.nih.gov |
| Novel Kidney Injury Tools in Deceased Organ Donation to Predict Graft Outcomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,054,144 | August 15, 2012 | November 30, 2026 | PARIKH, CHIRAG R | reporter.nih.gov |
| Manganese Based MRI Contrast Agent - First In Human Clinical Trial | NIH | National Cancer Institute | 2021 to 2022 | $2,053,452 | September 24, 2021 | December 31, 2023 | HOFFMAN, VERA | reporter.nih.gov |
| Unraveling the Impact of Per- and Polyfluoroalkyl Substances on Early Kidney Injury in Adolescents with Obesity and Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,052,411 | August 27, 2021 | June 30, 2026 | BJORNSTAD, PETTER | reporter.nih.gov |
| Development of a novel dual HIF-α inhibitor and inducer of ferroptosis for kidney cancer | NIH | National Cancer Institute | 2022 to 2023 | $2,050,000 | June 1, 2018 | August 31, 2025 | LIPPERT, ROBERT | reporter.nih.gov |
| Chronic Renal Insufficiency Cohort (CRIC) Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,049,079 | September 28, 2001 | June 30, 2026 | RAO, PANDURANGA S | reporter.nih.gov |
| Treating Kidney Injury by Modulating Heat Shock Proteins Using Soundwaves Combined with Mesenchymal Stem Cells and Their Extracellular Vesicles | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,048,853 | August 30, 2021 | July 31, 2025 | THAKOR, AVNESH SINH | reporter.nih.gov |
| KULMAP: Human Kidney, urinary tract and lung mapping center | NIH | National Heart, Lung, and Blood Institute | 2021 | $2,048,510 | September 25, 2018 | December 31, 2022 | ZHANG, KUN | reporter.nih.gov |
| Molecular Mechanisms Regulating Epithelial Cell Apical Polarity and Ciliogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,046,879 | January 15, 2004 | June 30, 2028 | PREKERIS, RYTIS | reporter.nih.gov |
| Role of Kidney Proximal Tubular Secretion in Critical Illness | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,046,382 | May 1, 2020 | April 30, 2025 | KESTENBAUM, BRYAN R | reporter.nih.gov |
| Establishing Strategies to Ameliorate Amyloid Pathology in Light Chain Amyloidosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,046,018 | May 5, 2016 | June 30, 2025 | WISEMAN, ROCKLAND LUKE | reporter.nih.gov |
| A Low Blood Volume Platform for Recurrent Anticoagulation and Kidney Monitoring during Continuous Renal Replacement Therapy in Critically Ill Children | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,044,830 | May 23, 2022 | May 31, 2026 | PAMULA, VAMSEE K. | reporter.nih.gov |
| Limited Competition for the Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Hopkins Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,040,107 | September 28, 2001 | June 30, 2026 | APPEL, LAWRENCE JOHN | reporter.nih.gov |
| A silicon nanopore membrane blood filter enabling anticoagulant free continuous renal replacement therapy for acute kidney injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $2,039,937 | September 19, 2019 | January 31, 2026 | BLAHA, CHARLES | reporter.nih.gov |
| Development of a mechanistically novel Gram-negative antibiotic targeting MsbA-mediated Lipopolysaccharide Biogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,038,369 | November 4, 2022 | October 31, 2027 | ROEMER, TERRY | reporter.nih.gov |
| Disease-specific risk factors for thrombosis following vascular interventions | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,033,473 | August 1, 2023 | July 31, 2027 | CHITALIA, VIPUL C | reporter.nih.gov |
| Skeletal Health in Type 1 Diabetes and the Role of Diabetic Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,026,915 | September 10, 2020 | July 31, 2025 | SCHAFER, ANNE LOUISE | reporter.nih.gov |
| Renal Molecular Imaging of Mesangial Cell Function with Tc-99m-Tilmanocept | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,025,043 | April 1, 2021 | February 28, 2026 | HOH, CARL K | reporter.nih.gov |
| Clinical and economic value of novel diabetes medications for prevention of cardiovascular disease in type 2 diabetes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,024,083 | May 1, 2021 | April 30, 2025 | FERKET, BART | reporter.nih.gov |
| Development of Magnetic Resonance Fingerprinting in Kidney for Evaluation of Renal Cell Carcinoma | NIH | National Cancer Institute | 2022 to 2025 | $2,023,294 | September 20, 2022 | August 31, 2027 | CHEN, YONG | reporter.nih.gov |
| Synthetic Mesenchymal Stem Cell Niches for Vascular Therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,023,009 | August 15, 2013 | July 31, 2025 | TAN, WEI | reporter.nih.gov |
| Continuous allocation score design for guaranteeing equity and reducing discards in kidney and liver transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,022,974 | December 17, 2022 | November 30, 2027 | MASSIE, ALLAN B | reporter.nih.gov |
| Defining the Pathogenesis and Prognosis of Human Acute Interstitial Nephritis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,021,164 | September 14, 2020 | June 30, 2025 | CANTLEY, LLOYD G | reporter.nih.gov |
| Mechanisms and Ex Vivo Repair of Cold-Storage Injury in Human Kidney Allografts | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,018,635 | February 28, 2020 | January 31, 2026 | POBER, JORDAN S | reporter.nih.gov |
| Molecular mechanisms of uropathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,017,860 | August 1, 2005 | June 30, 2025 | PEARSON, MELANIE M. | reporter.nih.gov |
| Cardiovascular effects of oral bicarbonate in CKD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,014,849 | August 24, 2022 | July 31, 2027 | RAPHAEL, KALANI LUKELA | reporter.nih.gov |
| Identification of new therapeutic targets for ADPKD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,012,444 | September 1, 2021 | June 30, 2025 | SKOLNIK, EDWARD Y | reporter.nih.gov |
| Non-SteroidAl Impact on Kidney Disease Study (NSAIDS) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,009,118 | May 15, 2023 | March 31, 2028 | ESTRELLA, MICHELLE M | reporter.nih.gov |
| Sympatho-inhibition with Mindfulness in Chronic Kidney Disease | NIH | National Center for Complementary & Integrative Health | 2022 to 2024 | $2,007,982 | September 1, 2019 | August 31, 2025 | PARK, JEANIE | reporter.nih.gov |
| Skeletal FGF23 production mediated by GPCR/Gq/PKC signaling | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,006,965 | April 1, 2020 | March 31, 2026 | BASTEPE, MURAT | reporter.nih.gov |
| Identification and Validation of Biological Sub-phenotypes of Sepsis-induced Acute Kidney Injury: A Precision Medicine Approach to Improve Clinical Outcomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,006,521 | August 1, 2022 | July 31, 2027 | BHATRAJU, PAVAN KUMAR | reporter.nih.gov |
| Perfluoroalkyl substances and risk of kidney cancer in US men and women | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $2,005,561 | June 20, 2023 | May 31, 2027 | ZHENG, TONGZHANG | reporter.nih.gov |
| The role of cytosolic nucleotide sensors in inflammatory fibrosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,005,025 | August 1, 2022 | May 31, 2027 | SUSZTAK, KATALIN | reporter.nih.gov |
| The novel role of HLA-E restricted CD8 regulatory T cells in kidney allograft rejection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,004,858 | July 12, 2023 | June 30, 2028 | AZZI, JAMIL | reporter.nih.gov |
| DNA methylation in kidney repair after ischemic AKI | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,003,352 | September 1, 2001 | August 31, 2027 | DONG, ZHENG | reporter.nih.gov |
| Long-acting PTH for hypoparathyroidism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $2,000,000 | September 24, 2015 | May 31, 2023 | HALES, LAURA M | reporter.nih.gov |
| Enhancing multidisciplinary research at Mayo with a state-of-the-art 7T preclinical MRI | NIH | Office of the Director, National Institutes of Health | 2025 | $2,000,000 | April 1, 2025 | March 31, 2027 | YIN, MENG | reporter.nih.gov |
| Long-acting PTH for hypoparathyroidism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,999,230 | September 1, 2024 | August 31, 2026 | HALES, LAURA M | reporter.nih.gov |
| A Bullet Proof vascular graft to prevent dialysis access cannulation injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,999,167 | September 1, 2016 | June 30, 2023 | KNIGHT, JOSEPH | reporter.nih.gov |
| A population-based study of deep learning derived organ and tissue measures for accelerated aging using repurposed abdominal CT images | NIH | National Institute on Aging | 2023 to 2025 | $1,998,355 | September 30, 2023 | May 31, 2028 | RULE, ANDREW DAVID | reporter.nih.gov |
| Off target mechanisms of kinase inhibitor toxicities | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,998,088 | April 1, 2022 | February 28, 2027 | PABLA, NAVJOT | reporter.nih.gov |
| Development of the NephroPlate: A high-throughput kidney-on-a-chip platform for identifying chronic kidney disease therapies | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $1,993,146 | September 28, 2020 | April 30, 2025 | CHANDLER, MORGAN | reporter.nih.gov |
| Trophic interactions directing proper kidney development | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,991,995 | February 21, 2020 | May 31, 2030 | O'BRIEN, LORI L | reporter.nih.gov |
| Early detection, containment, and management of COVID-19 in dialysis facilities using multi-modal data sources | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,991,343 | December 21, 2020 | November 30, 2025 | WANG, YUEDONG | reporter.nih.gov |
| Neonatal and Young Pediatric Kidney Preservation through Nanowarming and Vitrification | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,991,119 | September 14, 2018 | June 30, 2027 | WEEGMAN, BRADLEY P | reporter.nih.gov |
| A Hybrid Type 1 Effectiveness-Implementation Study of Education Strategies for Vascular Access Creation in Advanced Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,989,019 | January 1, 2023 | December 31, 2027 | FLYTHE, JENNIFER E | reporter.nih.gov |
| Mechanistic Studies on Meprin Metalloproteases and Meprin-Substrate Interactions in Tissue Injury | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,988,912 | June 1, 2021 | May 31, 2027 | ONGERI, ELIMELDA MOIGE | reporter.nih.gov |
| Greatly Extended Subzero Ischemic Storage of Renal Allografts Using Novel Bio-inspired Next Generation Cryoprotectants | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $1,986,927 | August 1, 2023 | May 31, 2026 | KLINE, MARK A | reporter.nih.gov |
| Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,984,415 | August 20, 2021 | June 30, 2026 | PATEL, KAUSHIK P | reporter.nih.gov |
| Role of disrupted polyamine synthesis during CKD-MBD related bone loss | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,983,733 | December 15, 2021 | November 30, 2026 | CLINKENBEARD, ERICA L | reporter.nih.gov |
| Novel regulatory mechanisms of the glomerular endothelium | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,983,511 | September 3, 2019 | August 31, 2030 | PETI-PETERDI, JANOS | reporter.nih.gov |
| Pathogenesis of renal injury and hypertension in HIV+ children | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,983,024 | April 15, 2023 | February 28, 2027 | RAY, PATRICIO E. | reporter.nih.gov |
| CD14 and Salt-Sensitive Hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,981,964 | July 1, 2022 | June 30, 2027 | MATTSON, DAVID L. | reporter.nih.gov |
| Improving marginal allograft outcomes through cell junction stabilization in transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,981,284 | April 15, 2020 | March 31, 2024 | GREK, CHRISTINA | reporter.nih.gov |
| Cellular and Molecular Basis of Sex Specificity in UTI Pathogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,975,613 | September 15, 2020 | July 31, 2025 | HUNSTAD, DAVID | reporter.nih.gov |
| Mechanisms of Kidney Diseases Associated With APOL1 Variation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,973,997 | February 2, 2023 | December 31, 2026 | SEDOR, JOHN R. | reporter.nih.gov |
| Renal Macrophage Biology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,972,617 | May 1, 2022 | February 28, 2027 | QIN, XUEBIN | reporter.nih.gov |
| REGULATORS OF CALCINEURIN PATHWAYS AS DIAGNOSTIC AND THERAPEUTIC TARGETS FOR NEPHROTIC SYNDROME | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,970,219 | February 1, 2023 | December 31, 2026 | GBADEGESIN, RASHEED ADEBAYO | reporter.nih.gov |
| Novel Type 1 Pilus Receptors in Pyelonephritis and Recurrent UTI | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,968,750 | April 1, 2021 | March 31, 2027 | HUNSTAD, DAVID | reporter.nih.gov |
| Leveraging the ESRD Treatment Choices model to understand the benefits of home versus in-center dialysis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,967,630 | July 1, 2023 | May 31, 2027 | SHAHINIAN, VAHAKN B | reporter.nih.gov |
| Racial disparities in access to kidney transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,967,199 | December 6, 2017 | March 31, 2029 | KU, ELAINE | reporter.nih.gov |
| Genetics of IgA nephropathy by integrative network-based association studies | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,965,032 | June 17, 2015 | May 31, 2027 | KIRYLUK, KRZYSZTOF | reporter.nih.gov |
| Breaking the Scope Port Size Barrier: A New Kind of Endoscope that Removes Large Kidney Stones Rapidly | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $1,957,949 | August 1, 2023 | June 30, 2026 | GAFFORD, JOSHUA B | reporter.nih.gov |
| American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,955,664 | July 9, 2019 | June 30, 2025 | UNRUH, MARK LYNN | reporter.nih.gov |
| Post Cardiac Surgery Hemodynamics Diagnostic Device | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2023 | $1,955,638 | September 30, 2022 | July 31, 2025 | KOTTAM, ANIL | reporter.nih.gov |
| Autonomic control of kidney function | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,954,988 | June 15, 2023 | April 30, 2027 | ZEIDEL, MARK L. | reporter.nih.gov |
| Design of a bioactive mimetic of soluble klotho for the treatment of chronic kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,954,883 | June 1, 2023 | May 31, 2027 | YANUCIL, CHRISTOPHER | reporter.nih.gov |
| Artificial Intelligence to Predict Outcomes in Patients with Acute Kidney Injury on Continuous Renal Replacement Therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,953,679 | April 1, 2023 | January 31, 2027 | NEYRA, JAVIER A. | reporter.nih.gov |
| Injury Response Mediated Pathogenesis in Renal Ciliopathies | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,950,967 | February 1, 2023 | November 30, 2026 | YODER, BRADLEY K. | reporter.nih.gov |
| Cell Biology of Vasopressin-induced Water Channels | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,949,999 | September 20, 2012 | March 31, 2027 | BROWN, DENNIS | reporter.nih.gov |
| Development of a Precision Medicine-based Diagnostic Tool for Membranous Nephropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $1,949,264 | July 15, 2021 | May 31, 2025 | LARSEN, CHRISTOPHER P | reporter.nih.gov |
| VisR Ultrasound for Monitoring Antibody-Mediated Rejection in Renal Transplant Patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,948,258 | March 1, 2016 | November 30, 2027 | GALLIPPI, CATERINA M | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of Pennsylvania | Philadelphia, PA | 54 | $93.9 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 65 | $92.7 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 85 | $87.7 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 81 | $85.6 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 67 | $76.2 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 45 | $73.7 million | 0 | $0 |
| Duke University | Durham, NC | 46 | $70.8 million | 0 | $0 |
| Yale University | New Haven, CT | 62 | $68.3 million | 0 | $0 |
| University of Washington | Seattle, WA | 49 | $67.9 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 48 | $65.4 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 54 | $65.3 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 46 | $63.4 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 59 | $60.2 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 49 | $60.1 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 62 | $58.6 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 50 | $57.1 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 36 | $50.9 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 45 | $50.3 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 36 | $47.3 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 31 | $47 million | 0 | $0 |
| Washington University | Saint Louis, MO | 46 | $46.5 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 50 | $43.3 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 27 | $38.6 million | 0 | $0 |
| Stanford University | Stanford, CA | 39 | $36.7 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 19 | $35.6 million | 0 | $0 |
| Emory University | Atlanta, GA | 45 | $35.6 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 22 | $34.6 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 10 | $33.3 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 20 | $31.7 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 28 | $31.2 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 28 | $29.9 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 35 | $29.6 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 29 | $28.6 million | 0 | $0 |
| University of Florida | Gainesville, FL | 28 | $25 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 17 | $23 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 24 | $22.5 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 20 | $21.9 million | 0 | $0 |
| Augusta University | Augusta, GA | 20 | $21.1 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 19 | $20.8 million | 0 | $0 |
| University of Tennessee Health Sci CTR | Memphis, TN | 13 | $20.7 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 19 | $20.6 million | 0 | $0 |
| University of Connecticut SCH of Med/dnt | Farmington, CT | 8 | $20.1 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 14 | $19.7 million | 0 | $0 |
| Dartmouth College | Hanover, NH | 3 | $18.9 million | 0 | $0 |
| Boston Medical Center | Boston, MA | 14 | $18.8 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 22 | $18.3 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 9 | $17.9 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 12 | $17.7 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 20 | $17.1 million | 0 | $0 |
| Research Inst Nationwide Children's Hosp | Columbus, OH | 14 | $15.4 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 13 | $14.5 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 14 | $14.4 million | 0 | $0 |
| Northern California Institute/res/edu | San Francisco, CA | 6 | $14.3 million | 0 | $0 |
| Rush University Medical Center | Chicago, IL | 12 | $14.2 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 15 | $14.1 million | 0 | $0 |
| Dana-Farber Cancer Inst | Boston, MA | 8 | $14 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 15 | $13.7 million | 0 | $0 |
| University of South Florida | Tampa, FL | 14 | $13.7 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 14 | $13.6 million | 0 | $0 |
| University of Chicago | Chicago, IL | 10 | $12.8 million | 0 | $0 |
| SUNY at Stony Brook | Stony Brook, NY | 18 | $12.5 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 7 | $12.5 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 20 | $12.4 million | 0 | $0 |
| Joslin Diabetes Center | Boston, MA | 6 | $12.1 million | 0 | $0 |
| Tufts Medical Center | Boston, MA | 7 | $11.9 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 13 | $11.5 million | 0 | $0 |
| Hennepin Healthcare Research Institute | Minneapolis, MN | 8 | $11 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 9 | $10.7 million | 0 | $0 |
| Brown University | Providence, RI | 7 | $10.5 million | 0 | $0 |
| Wayne State University | Detroit, MI | 11 | $10.5 million | 0 | $0 |
| University of Mississippi Med CTR | Jackson, MS | 13 | $10.4 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 10 | $10.2 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 8 | $10.2 million | 0 | $0 |
| University of Houston | Houston, TX | 10 | $10 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 13 | $9.9 million | 0 | $0 |
| University of Rochester | Rochester, NY | 14 | $9.8 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 13 | $9.8 million | 0 | $0 |
| Ohio State University | Columbus, OH | 12 | $9.7 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 7 | $9.6 million | 0 | $0 |
| Children's Hospital of Los Angeles | Los Angeles, CA | 5 | $9.2 million | 0 | $0 |
| George Washington University | Washington, DC | 5 | $8.8 million | 0 | $0 |
| Veterans Medical Research Fdn/san Diego | San Diego, CA | 8 | $8.8 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 13 | $8.7 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 10 | $8.5 million | 0 | $0 |
| Reveal Pharma | Cambridge, MA | 4 | $8.5 million | 0 | $0 |
| University of Calgary | Calgary | 1 | $8.5 million | 0 | $0 |
| New York Medical College | Valhalla, NY | 7 | $8.1 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 8 | $7.7 million | 0 | $0 |
| University of California at Davis | Davis, CA | 5 | $7.7 million | 0 | $0 |
| Rogosin Institute | New York, NY | 1 | $7.4 million | 0 | $0 |
| Research Triangle Institute | Research Triangle Park, NC | 1 | $7.4 million | 0 | $0 |
| Georgetown University | Washington, DC | 8 | $7.3 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 7 | $7.1 million | 0 | $0 |
| Pennsylvania State Univ University Park | University Park, PA | 5 | $7 million | 0 | $0 |
| Rutgers University New Brunswick | New Brunswick, NJ | 6 | $7 million | 0 | $0 |
| Univ of Arkansas for Med Scis | Little Rock, AR | 4 | $7 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 8 | $6.8 million | 0 | $0 |
| Aronora, Inc. | Portland, OR | 2 | $6.8 million | 0 | $0 |
| Palo Alto Veterans Instit for Research | Palo Alto, CA | 4 | $6.6 million | 0 | $0 |
| Feinstein Institute for Medical Research | Manhasset, NY | 6 | $6.5 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 1,193 | $630,920,180 | 0 | $0 |
| 2024 | 1,316 | $619,088,640 | 0 | $0 |
| 2023 | 1,332 | $614,751,889 | 0 | $0 |
| 2022 | 1,316 | $592,635,786 | 0 | $0 |
| 2021 | 1,306 | $565,454,906 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.